Stanisław Konturek

Stanisław Konturek's AcademicInfluence.com Rankings

Stanisław Konturek

Biology

#2964

World Rank

#4608

Historical Rank

Physiology

#59

World Rank

#163

Historical Rank

biology Degrees

Download Badge

Biology

Stanisław Konturek's Degrees

Doctorate Medicine Medical University of Warsaw
PhD Physiology University of Warsaw

Why Is Stanisław Konturek Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Stanisław Jan Konturek was a Polish physiologist and gastroenterologist, a member of the Polish Academy of Sciences and the Polish Academy of Learning, and professor of Jagiellonian University Collegium Medicum.

(See a Problem?)

Stanisław Konturek's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Gastric electrical stimulation for medically refractory gastroparesis. (2003) (532)
Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. (2011) (452)
Brain-gut axis and its role in the control of food intake. (2004) (447)
Brain-gut axis and its role in the control of food intake. (2004) (447)
Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. (2002) (312)
Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. (1988) (279)
Gastric Electrical Stimulation in Intractable Symptomatic Gastroparesis (2003) (273)
Inhibition of acid secretion in dog by metiamide, a histamine antagonist acting on H2 receptors. (1974) (256)
Gut clock: implication of circadian rhythms in the gastrointestinal tract. (2011) (245)
Role of prostaglandins in gastroprotection and gastric adaptation. (2005) (219)
Neuro-hormonal control of food intake: basic mechanisms and clinical implications. (2005) (213)
Neuro-hormonal control of food intake: basic mechanisms and clinical implications. (2005) (213)
Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats. (1982) (205)
Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. (1993) (192)
Gastric cytoprotection by epidermal growth factor: Role of endogenous prostaglandins and DNA synthesis (1981) (171)
Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. (2007) (166)
Helicobacter pylori infection in gastric cancerogenesis. (2009) (162)
Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage (2004) (156)
Gastroprotective effects of flavonoids in plant extracts. (2005) (156)
Distribution and release of epidermal growth factor in man. (1989) (155)
Distribution and release of epidermal growth factor in man. (1989) (155)
Transforming growth factor alpha and epidermal growth factor in protection and healing of gastric mucosal injury. (1992) (150)
Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). (2007) (149)
Role of prostaglandins in the formation of aspirin-induced gastric ulcers (1981) (142)
Somatostatin and the gastrointestinal secretions. (1976) (141)
Brain-gut axis in pancreatic secretion and appetite control. (2003) (139)
Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin. (1976) (137)
Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions. (1990) (136)
Melatonin and aging: prospects for human treatment. (2011) (136)
Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion. (1976) (133)
The role of melatonin and L‐tryptophan in prevention of acute gastric lesions induced by stress, ethanol, ischemia, and aspirin (1997) (130)
Classic NSAID and selective cyclooxygenase (COX)‐1 and COX‐2 inhibitors in healing of chronic gastric ulcers (2001) (130)
Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases. (2015) (129)
Role of oxidative stress in the pathogenesis of caerulein-induced acute pancreatitis. (1999) (129)
Role of melatonin in upper gastrointestinal tract. (2007) (129)
Role of oxidative stress in the pathogenesis of caerulein-induced acute pancreatitis. (1999) (129)
Ghrelin attenuates the development of acute pancreatitis in rat. (2003) (126)
Ghrelin-a new gastroprotective factor in gastric mucosa. (2004) (117)
Neuroendocrinology of the pancreas; role of brain-gut axis in pancreatic secretion. (2003) (109)
Neuroendocrinology of the pancreas; role of brain-gut axis in pancreatic secretion. (2003) (109)
Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves. (2009) (108)
Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions. (1999) (105)
Proof of a pyloro-oxyntic reflex for stimulation of acid secretion. (1974) (104)
Protective effect of melatonin and its precursor L‐tryptophan on acute pancreatitis induced by caerulein overstimulation or ischemia/reperfusion (2003) (103)
Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. (1998) (103)
Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. (1998) (103)
Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up. (2014) (100)
Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide. (2006) (100)
Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins. (1987) (100)
Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers. (2000) (99)
Effect of Adiponectin and Ghrelin on Apoptosis of Barrett Adenocarcinoma Cell Line (2008) (98)
Prostaglandins and ulcer healing. (2005) (98)
Melatonin in gastroprotection against stress-induced acute gastric lesions and in healing of chronic gastric ulcers. (2006) (97)
Role of endogenous nitric oxide in the control of canine pancreatic secretion and blood flow. (1993) (96)
Role of platelet activating factor in pathogenesis of acute pancreatitis in rats. (1992) (95)
Gastric cytoprotection by epidermal growth factor. Role of endogenous prostaglandins and DNA synthesis. (1981) (94)
Prostaglandins as mediators of COX-2 derived carcinogenesis in gastrointestinal tract. (2005) (93)
Leptin in gastroprotection induced by cholecystokinin or by a meal. Role of vagal and sensory nerves and nitric oxide. (1999) (92)
Role of mucosal prostaglandins and DNA synthesis in gastric cytoprotection by luminal epidermal growth factor. (1981) (92)
Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. (2009) (90)
Activation of genes for superoxide dismutase, interleukin-1beta, tumor necrosis factor-alpha, and intercellular adhesion molecule-1 during healing of ischemia-reperfusion-induced gastric injury. (2000) (90)
Epidermal growth factor and transforming growth factor-alpha: role in protection and healing of gastric mucosal lesions. (1995) (89)
Endogenous nitric oxide in the control of esophageal motility in humans. (1997) (87)
Effect of perfusion of intestinal loops with acid, fat, or dextrose on gastric secretion. (1965) (87)
Endogenous nitric oxide in the control of esophageal motility in humans. (1997) (87)
Helicobacter pylori associated gastric pathology. (1999) (86)
Role of leptin in ulcer healing. (2001) (85)
Gastroprotective activity of melatonin and its precursor, L-tryptophan, against stress-induced and ischaemia-induced lesions is mediated by scavenge of oxygen radicals. (1997) (85)
Melatonin affords protection against gastric lesions induced by ischemia-reperfusion possibly due to its antioxidant and mucosal microcirculatory effects. (1997) (85)
Comparison of methionine-enkephalin and morphine in the stimulation of gastric acid secretion in the dog. (1980) (84)
Helicobacter pylori induces apoptosis in gastric mucosa through an upregulation of Bax expression in humans. (1999) (83)
The role of reactive oxygen species in action of nitric oxide-donors on stress-induced gastric mucosal lesions. (2002) (83)
Effect of extragastric and truncal vagotomy on pancreatic secretion in the dog. (1975) (82)
The effects of long-term melatonin treatment on plasma liver enzymes levels and plasma concentrations of lipids and melatonin in patients with nonalcoholic steatohepatitis: a pilot study. (2012) (81)
Role of reactive oxygen metabolites in aspirin‐induced gastric damage in humans: gastroprotection by vitamin C (2001) (80)
Role of prostaglandins in the formation of aspirin-induced gastric ulcers. (1981) (80)
Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: effects of aspirin and paracetamol. (1981) (80)
Apoptosis in gastric mucosa with stress-induced gastric ulcers. (1999) (80)
Role of the adrenal cortex in gastric mucosal protection by prostaglandins, sulfhydryls, and cimetidine in the rat. (1983) (79)
Effect of bombesin and related peptides on the release and action of intestinal hormones on pancreatic secretion. (1976) (79)
Oral cavity as permanent reservoir of Helicobacter pylori and potential source of reinfection. (1996) (79)
Effects of epidermal growth factor on gastrointestinal secretions. (1984) (78)
Effects of epidermal growth factor on gastrointestinal secretions. (1984) (78)
Comparison of methylated prostaglandin E2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man. (1976) (77)
Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients. (1980) (76)
Antiulcer and gastroprotective effects of solon, a synthetic flavonoid derivative of sophoradin. Role of endogenous prostaglandins. (1986) (76)
Role of prostaglandins in control of intestinal motility. (1985) (75)
Cholecystokinin receptors and vagal nerves in control of food intake in rats. (1990) (75)
Role of prostaglandins in control of intestinal motility. (1985) (75)
Bicarbonate and cyclic AMP content of pure human pancreatic juice in response to graded doses of synthetic secretin. (1976) (75)
Expression of Survivin and Caspase-3 in Gastric Cancer (2003) (74)
Effect of moderate incremental exercise, performed in fed and fasted state on cardio-respiratory variables and leptin and ghrelin concentrations in young healthy men. (2005) (74)
The photoperiod, circadian regulation and chronodisruption: the requisite interplay between the suprachiasmatic nuclei and the pineal and gut melatonin. (2011) (74)
Probiotic bacteria Escherichia coli strain Nissle 1917 attenuates acute gastric lesions induced by stress. (2009) (73)
Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man. (1983) (73)
Role of capsaicin-sensitive sensory nerves in gastroprotection against acid-independent and acid-dependent ulcerogens. (1996) (73)
Prostaglandin/Cyclooxygenase Pathway in Ghrelin-Induced Gastroprotection against Ischemia-Reperfusion Injury (2006) (73)
New approach to 13C-urea breath test: capsule-based modification with low-dose of 13C-urea in the diagnosis of Helicobacter pylori infection. (1996) (73)
Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers. (2003) (72)
Gastroprotection by pentoxyfilline against stress-induced gastric damage. Role of lipid peroxidation, antioxidizing enzymes and proinflammatory cytokines. (2004) (72)
Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats. (1983) (71)
Involvement of endogenous cholecystokinin and somatostatin in gastroprotection induced by intraduodenal fat. (1998) (71)
Gastric cytoprotection by prostaglandins, ranitidine, and probanthine in rats. Role of endogenous prostaglandins. (1981) (71)
Cytoprotection of canine gastric mucosa by prostacyclin: possible mediation by increased mucosal blood flow. (1982) (71)
Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication an coronary lumen reduction after percutations coronaryangioplasty (2001) (71)
From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century. (2005) (70)
From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century. (2005) (70)
Cannabinoids in acute gastric damage and pancreatitis. (2006) (70)
Melatonin and its role in oxidative stress related diseases of oral cavity. (2007) (69)
Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. (2007) (69)
Helicobacter pylori and its eradication in rosacea. (1999) (68)
Diffuse esophageal spasm: a malfunction that involves nitric oxide? (1995) (68)
Relationship of clinical features and laboratory parameters to thyroid echogenicity measured by standardized grey scale ultrasonography in patients with Hashimoto's thyroiditis. (2003) (68)
Release of Cholecystokinin by Amino Acids (1973) (68)
Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor. (2000) (68)
Helicobacter pylori in the oral cavity and its implications for gastric infection, periodontal health, immunology and dyspepsia. (2005) (67)
Therapeutic Potential of 1-Methylnicotinamide against Acute Gastric Lesions Induced by Stress: Role of Endogenous Prostacyclin and Sensory Nerves (2008) (67)
Effects of nicotine on gastrointestinal secretions.. (1971) (67)
Epidermal Growth Factor in Protection, Repair, and Healing of Gastroduodenal Mucosa (1991) (67)
Effects of nitric oxide on antral motility and gastric emptying in humans. (1995) (67)
Role of salivary glands and epidermal growth factor (EGF) in gastric secretion and mucosal integrity in rats exposed to stress (1991) (67)
Association of the presence of Helicobacter pylori in the oral cavity and in the stomach. (2004) (67)
Epidermal Growth Factor in Protection, Repair, and Healing of Gastroduodenal Mucosa (1991) (67)
Expression of epidermal growth factor and transforming growth factor alpha during ulcer healing. Time sequence study. (1997) (66)
Ischemic preconditioning of remote organs attenuates gastric ischemia-reperfusion injury through involvement of prostaglandins and sensory nerves. (2004) (66)
Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells. (2003) (66)
Ischemic preconditioning, the most effective gastroprotective intervention: involvement of prostaglandins, nitric oxide, adenosine and sensory nerves. (2001) (65)
Relation between duodenal alkaline secretion and motility in fasted and sham-fed dogs. (1986) (65)
Helicobacter pylori infection in coronary artery disease. (2006) (65)
Helicobacter pylori infection in coronary artery disease. (2006) (65)
Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic secretion. (1976) (65)
Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor. (2004) (64)
[Gastric secretion in Zollinger-Ellison syndrome]. (1972) (64)
Helicobacter pylori infection and gastrin and cyclooxygenase expression in gastric and colorectal malignancies (2000) (64)
Effect of Local Application of Growth Factors on Gastric Ulcer Healing and Mucosal Expression of Cyclooxygenase-1 and -2 (2001) (64)
Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals. (2006) (63)
Gastric cancer and Helicobacter pylori infection. (2006) (63)
THE EFFECT OF ENDURANCE TRAINING ON MUSCLE STRENGTH IN YOUNG, HEALTHY MEN IN RELATION TO HORMONAL STATUS (2008) (63)
Inhibition by somatostatin of secretin-stimulated pancreatic secretion in man: a study with pure pancreatic juice. (1977) (63)
H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPAR gamma and impaired apoptosis in gastric carcinogenesis. (2003) (62)
Expression and release of leptin and proinflammatory cytokines in patients with ulcerative colitis and infectious diarrhea. (2012) (62)
H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPAR gamma and impaired apoptosis in gastric carcinogenesis. (2003) (62)
Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. (2002) (62)
Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. (2002) (62)
IGF-1 stimulates production of interleukin-10 and inhibits development of caerulein-induced pancreatitis. (2003) (62)
Leptin Modulates the Inflammatory Response in Acute Pancreatitis (2002) (61)
Mucosal adaptation to aspirin induced gastric damage in humans. Studies on blood flow, gastric mucosal growth, and neutrophil activation. (1994) (61)
Role of growth factors in gastroduodenal protection and healing of peptic ulcers. (1990) (61)
Mucosal adaptation to aspirin induced gastric damage in humans. Studies on blood flow, gastric mucosal growth, and neutrophil activation. (1994) (61)
Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, accelerates gastric ulcer healing in rat. (2003) (60)
Impaired gastric ulcer healing in diabetic rats: role of heat shock protein, growth factors, prostaglandins and proinflammatory cytokines. (2003) (59)
Importance of brain-gut axis in the gastroprotection induced by gastric and remote preconditioning. (2004) (59)
Influence of chronic Helicobacter pylori infection on ischemic cerebral stroke risk factors. (2002) (59)
Expression of cyclooxygenase (COX)-1 and COX-2 in adaptive cytoprotection induced by mild stress (2000) (59)
Role of gastric blood flow, neutrophil infiltration, and mucosal cell proliferation in gastric adaptation to aspirin in the rat. (1994) (59)
Effects of omeprazole, a substituted benzimidazole, on gastrointestinal secretions, serum gastrin, and gastric mucosal blood flow in dogs (1984) (58)
Effect of glucagon on meal-induced gastric secretion in man. (1975) (58)
Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl‐2, and gastrin in human gastric cancer (2001) (58)
Effects of omeprazole, a substituted benzimidazole, on gastrointestinal secretions, serum gastrin, and gastric mucosal blood flow in dogs (1984) (58)
Role of endogenous gastrin in gastroprotection. (1995) (58)
Fibroblast growth factor in gastroprotection and ulcer healing: interaction with sucralfate. (1993) (58)
Brain-gut axis in gastroprotection by leptin and cholecystokinin against ischemia-reperfusion induced gastric lesions. (2001) (58)
Double blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man. (1986) (58)
Healing of chronic gastric ulcerations by L-arginine. Role of nitric oxide, prostaglandins, gastrin and polyamines. (1995) (57)
Discovery by Jaworski of Helicobacter pylori and its pathogenetic role in peptic ulcer, gastritis and gastric cancer. (2003) (57)
Protective and therapeutic effect of heparin in acute pancreatitis. (2008) (57)
The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin. (2010) (57)
Adrenergic pathway in the inhibition of pancreatic secretion by peptide YY in dogs. (1988) (57)
Role of locally generated prostaglandins in adaptive gastric cytoprotection (1982) (57)
Gastric ulcer healing and stress-lesion preventive properties of pioglitazone are attenuated in diabetic rats. (2010) (56)
Effect of somatostatin on myoelectrical activity of small bowel. (1978) (56)
Cytoprotective and ulcer healing properties of prostaglandin E2, colloidal bismuth and sucralfate in rats. (1987) (55)
Grapefruit-seed extract attenuates ethanol-and stress-induced gastric lesions via activation of prostaglandin, nitric oxide and sensory nerve pathways. (2005) (55)
Central Leptin and Cholecystokinin in Gastroprotection against Ethanol-Induced Damage (2000) (55)
Association of Helicobacter pylori infection with coronary heart disease. (1999) (55)
Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with non-ulcer dyspesia. (1996) (54)
Melatonin and its precursor, L‐tryptophan: influence on pancreatic amylase secretion in vivo and in vitro (2004) (54)
Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with non-ulcer dyspesia. (1996) (54)
The effects of L-tryptophan and melatonin on selected biochemical parameters in patients with steatohepatitis. (2010) (53)
The relationship between the presence of Helicobacter pylori in the oral cavity and gastric in the stomach. (2006) (53)
Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats. (1988) (53)
Protective influence of melatonin against acute esophageal lesions involves prostaglandins, nitric oxide and sensory nerves. (2007) (53)
Pancreatic damage and regeneration in the course of ischemia-reperfusion induced pancreatitis in rats. (2001) (53)
Effect of Probiotics and Triple Eradication Therapy on the Cyclooxygenase (COX)‐2 Expression, Apoptosis, and Functional Gastric Mucosal Impairment in Helicobacter pylori‐Infected Mongolian Gerbils (2006) (53)
Comparison of nitric oxide-releasing NSAID and vitamin C with classic NSAID in healing of chronic gastric ulcers; involvement of reactive oxygen species. (2001) (52)
Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer. (2000) (52)
Duodenal mucosal protection by bicarbonate secretion and its mechanisms. (2004) (52)
Helicobacter pylori and CagA Status, Serum Gastrin, Interleukin-8 and Gastric Acid Secretion in Gastric Cancer (2002) (52)
Involvement of nitric oxide and prostaglandins in gastroprotection induced by bacterial lipopolysaccharide. (1998) (51)
Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori. (1997) (51)
Intravenous amino acids and fat stimulate pancreatic secretion. (1979) (51)
The role of reactive oxygen species and capsaicin-sensitive sensory nerves in the pathomechanisms of gastric ulcers induced by stress. (2003) (51)
Intravenous amino acids and fat stimulate pancreatic secretion. (1979) (51)
Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans. (1999) (51)
Epidermal growth factor in the gastroprotective and ulcer-healing actions of sucralfate in rats. (1989) (50)
Pioglitazone, a Specific Ligand of the Peroxisome Proliferator-Activated Receptor Gamma Reduces Gastric Mucosal Injury Induced by Ischaemia/Reperfusion in Rat (2003) (50)
Oral Cavity as a Potential Source of Gastric Reinfection by Helicobacter pylori (2002) (50)
Nitric oxide (NO)-releasing aspirin and (NO) donors in protection of gastric mucosa against stress. (2008) (50)
Helicobacter pylori promotes apoptosis, activates cyclooxygenase (COX)-2 and inhibits heat shock protein HSP70 in gastric cancer epithelial cells (2012) (49)
Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin (2013) (49)
Leptin Protects the Pancreas from Damage Induced by Caerulein Overstimulation by Modulating Cytokine Production (2002) (49)
Interaction of growth hormone-releasing factor and somatostatin on ulcer healing and mucosal growth in rats: role of gastrin and epidermal growth factor. (1988) (48)
Influence of bacterial lipopolysaccharide on healing of chronic experimental ulcer in rat. (2001) (48)
Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome. (2008) (48)
Role of epidermal growth factor in gastroprotection and ulcer healing. (1988) (48)
Prostaglandins and alkaline secretion from oxyntic, antral, and duodenal mucosa of the dog. (1983) (48)
Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase. (2006) (48)
Helicobacter pylori infection and serum gastrin, ghrelin and leptin in children of Polish shepherds. (2005) (48)
Gastric acid does drive pancreatic bicarbonate secretion. (1974) (47)
Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. (2001) (47)
Epidermal growth factor and prostaglandin E2 accelerate mucosal recovery from stress-induced gastric lesions via inhibition of apoptosis (2001) (47)
Cephalic phase of gastric secretion in healthy subjects and duodenal ulcer patients: role of vagal innervation. (1979) (47)
Role of nitric oxide and prostaglandins in gastroprotection induced by capsaicin and papaverine. (1993) (47)
Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans. (1990) (47)
Influence of leptin administration on the course of acute ischemic pancreatitis. (2002) (47)
Influence of gastric colonization with Candida albicans on ulcer healing in rats: Effect of ranitidine, aspirin and probiotic therapy (2005) (47)
Role of endogenous nitric oxide in the control of exocrine and endocrine pancreatic secretion in humans. (1997) (47)
Role of endogenous nitric oxide in the control of exocrine and endocrine pancreatic secretion in humans. (1997) (47)
Gut hormones in stimulation of gastroduodenal alkaline secretion in conscious dogs. (1985) (46)
Prevention of ethanol and aspirin-induced gastric mucosal lesions by paracetamol and salicylate in rats: role of endogenous prostaglandins. (1982) (46)
Gastroduodenal alkaline response to acid and taurocholate in conscious dogs. (1984) (45)
Protective Action of Lipopolysaccharidesin Rat Caerulein-Induced Pancreatitis: Role of Nitric Oxide (2000) (45)
Vasoactive intestinal peptide: a secretin-like partial agonist for pancreatic secretion in man. (1977) (45)
Cancerogenesis in Helicobacter pylori infected stomach--role of growth factors, apoptosis and cyclooxygenases. (2001) (45)
Enhanced expression of leptin following acute gastric injury in rat. (1999) (44)
Role of spasmolytic polypeptide in healing of stress-induced gastric lesions in rats (1997) (44)
Effect of medical and surgical vagotomy on gastric response to graded doses of pentagastrin and histamine. (1968) (44)
Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves (1999) (44)
Gene Expression of Ornithine Decarboxylase, Cyclooxygenase-2, and Gastrin in Atrophic Gastric Mucosa Infected with Helicobacter pylori Before and After Eradication Therapy (2004) (44)
Antigastric autoantibodies and gastric secretory function in Helicobacter pylori-infected patients with duodenal ulcer and non-ulcer dyspepsia. (1998) (44)
Effect of substance P and its C-terminal hexapeptide on gastric and pancreatic secretion in the dog. (1981) (44)
De-Nol stimulates gastric and duodenal alkaline secretion through prostaglandin dependent mechanism. (1987) (44)
Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients. (1994) (43)
Comparison of Somatostatin and Its Highly Potent Hexa- and Octapeptide Analogs on Exocrine and Endocrine Pancreatic Secretion (1988) (43)
Implications of Oral Helicobacter pylori for the Outcome of its Gastric Eradication Therapy (2007) (43)
Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins. (2008) (43)
Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients. (1994) (43)
Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs. (1975) (43)
Physiological role and localization of cholecystokinin release in dogs. (1986) (42)
Advances in the understanding of the mechanism of cytoprotective action by colloidal bismuth subcitrate. (1986) (42)
Physiology and pharmacology of prostaglandins (1986) (42)
Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, interacts with gastric oxidative metabolism and enhances stress-induced gastric lesions. (2012) (42)
Effect of pancreatic polypeptide and its C‐terminal hexapeptide on meal and secretin induced pancreatic secretion in dogs. (1981) (42)
Effect of calcium and calcitonin on gastrin and gastric secretion in cats. (1973) (42)
Plasma secretion and pancreatic secretion in response to liver extract meal with varied pH and exogenous secretin in the dog. (1982) (42)
Water Extracts of Helicobacter pylori Delay Healing of Chronic Gastric Ulcers in Rats: Role of Cytokines and Gastrin-Somatostatin Link (1999) (42)
Progastrin and Cyclooxygenase-2 in Colorectal Cancer (2002) (42)
Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans. (2011) (42)
Gastrointestinal secretory, motor, circulatory, and metabolic effects of prosomatostatin. (1981) (42)
Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2. (2001) (42)
Altered basal and postprandial plasma melatonin, gastrin, ghrelin, leptin and insulin in patients with liver cirrhosis and portal hypertension without and with oral administration of melatonin or tryptophan (2009) (41)
Mechanisms of esophageal protection, gastroprotection and ulcer healing by melatonin. implications for the therapeutic use of melatonin in gastroesophageal reflux disease (GERD) and peptic ulcer disease. (2014) (41)
Effects of an antral mucosectomy, L-364,718 and atropine on cephalic phase of gastric and pancreatic secretion in dogs. (1990) (41)
Expression of epidermal growth factor and transforming growth factor-alpha after exposure of rat gastric mucosa to stress. (1996) (41)
Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs. (2000) (41)
Gastric secretory and plasma hormonal responses to sham-feeding of varying duration in patients with duodenal ulcer. (1981) (41)
Pancreatic dose-response curves to intravenous secretin in man. (1970) (41)
Effect of vagotomy on hormones stimulating pancreatic secretion. (1974) (41)
Acid response to gastrin and related peptides. (1966) (40)
Gastric adaptation to injury by repeated doses of aspirin strengthens mucosal defence against subsequent exposure to various strong irritants in rats. (1995) (40)
Role of Helicobacter pylori infection in extragastroduodenal disorders: introductory remarks. (1999) (40)
Endogenous opiates and the digestive system. (1978) (40)
Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate. (1987) (40)
Influence of COX-2 Inhibition by Rofecoxib on Serum and Tumor Progastrin and Gastrin Levels and Expression of PPARγ and Apoptosis-Related Proteins in Gastric Cancer Patients (2003) (40)
Role of leukotrienes in acute gastric lesions induced by ethanol, taurocholate, aspirin, platelet-activating factor and stress in rats (1988) (40)
Effect of carprofen and indomethacin on gastric function, mucosal integrity and generation of prostaglandins in men. (1982) (40)
Influence of methionine-enkephalin and morphine on myoelectric activity of small bowel. (1980) (39)
Opiates and the gastrointestinal tract. (1980) (39)
Implications of reactive oxygen species and cytokines in gastroprotection against stress-induced gastric damage by nitric oxide releasing aspirin (2003) (39)
Involvement of Helicobacter pylori infection in neuro-hormonal control of food intake. (2006) (39)
Activation of genes for growth factors and cyclooxygenases in rat gastric mucosa during recovery from stress damage. (1998) (39)
Effect of metiamide, a histamine H2-receptor antagonist, on mucosal blood flow and serum gastrin level. (1974) (39)
Sensory nerves in central and peripheral control of pancreatic integrity by leptin and melatonin. (2002) (39)
Gastroprotective Effect of Histamine and Acid Secretion on Ammonia-Induced Gastric Lesions in Rats (2000) (39)
Helicobacter pylori, gastrin and cyclooxygenase-2 in lung cancer. (2000) (39)
Hepatocyte growth factor attenuates pancreatic damage in caerulein-induced pancreatitis in rats. (2001) (38)
Characteristics of inhibition of pancreatic secretion by glucagon. (1974) (38)
Nitric oxide inhibits the myoelectric activity of the small intestine in dogs. (1993) (38)
Interaction between selective cyclooxygenase inhibitors and capsaicin-sensitive afferent sensory nerves in pathogenesis of stress-induced gastric lesions. Role of oxidative stress. (2012) (38)
Immunohistochemical expression of FGF-2, PDGF-A, VEGF and TGF beta RII in the pancreas in the course of ischemia/reperfusion-induced acute pancreatitis. (2004) (38)
Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C. (2000) (37)
Role of brain-gut axis in healing of gastric ulcers. (2004) (37)
Effect of cholecystokinin receptor antagonist on pancreatic responses to exogenous gastrin and cholecystokinin and to meal stimuli. (1988) (37)
Helicobacter pylori and its involvement in gastritis and peptic ulcer formation. (2006) (37)
Role of capsaicin-sensitive nerves and histamine H1, H2, and H3 receptors in the gastroprotective effect of histamine against stress ulcers in rats. (2005) (37)
Extract of grapefruit-seed reduces acute pancreatitis induced by ischemia/reperfusion in rats: possible implication of tissue antioxidants. (2004) (37)
Cholecystokinin in the regulation of intestinal motility and pancreatic secretion in dogs. (1988) (37)
Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide. (2001) (37)
Inhibition of acid formation by epidermal growth factor in the isolated rabbit gastric glands. (1986) (37)
Helicobacter pylori and its involvement in gastritis and peptic ulcer formation. (2006) (37)
Effect of vagotomy on pancreatic secretion evoked by endogenous and exogenous cholecystokinin and caerulein. (1972) (37)
CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man. (1989) (36)
CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man. (1989) (36)
Protective effect of calcitonin gene-related peptide against caerulein-induced pancreatitis in rats. (1997) (36)
The circadian rhythm of melatonin modulates the severity of caerulein‐induced pancreatitis in the rat (2004) (36)
Role of endogenous melatonin and its MT2 receptor in the modulation of caerulein-induced pancreatitis in the rat. (2002) (36)
Mucosal strengthening activity of central and peripheral melatonin in the mechanism of gastric defense. (2009) (36)
Serum gastrin and gastric acid responses to meals at various pH levels in man (1974) (36)
Implication of peroxisome proliferator-activated receptor gamma and proinflammatory cytokines in gastric carcinogenesis: link to Helicobacter pylori-infection. (2004) (36)
Novel concept in the mechanism of injury and protection of gastric mucosa: role of renin-angiotensin system and active metabolites of angiotensin. (2012) (36)
Helicobacter pylori–gastrin link in MALT lymphoma (2000) (36)
Effect of local injection with basic fibroblast growth factor (BFGF) and neutralizing antibody to BFGF on gastric ulcer healing, gastric secretion, angiogenesis and gastric blood flow. (2001) (35)
Role of endogenous nitric oxide in the control of gastric acid secretion, blood flow and gastrin release in conscious dogs (1994) (35)
Mechanisms of nicotine-induced inhibition of pancreatic secretion of bicarbonate in the dog. (1972) (35)
Influence of ischemic preconditioning on blood coagulation, fibrinolytic activity and pancreatic repair in the course of caerulein-induced acute pancreatitis in rats. (2007) (35)
Bacterial Lipopolysaccharide Protects Gastric Mucosa against Acute Injury in Rats by Activation of Genes for Cyclooxygenases and Endogenous Prostaglandins (1998) (35)
Gastroprotective action of orexin-A against stress-induced gastric damage is mediated by endogenous prostaglandins, sensory afferent neuropeptides and nitric oxide (2008) (35)
Comparison of Epidermal Growth Factor and TransformingGrowth Factor-β1 Expression in Hormone-Induced Acute Pancreatitis in Rats (1998) (34)
Evidence for an enterogastric reflex for the inhibition of acid secretion. (1971) (34)
Leptin, gastrointestinal and stress hormones in response to exercise in fasted or fed subjects and before or after blood donation. (2001) (34)
Epidermal growth factor and transforming growth factor alpha in duodenal ulcer and non-ulcer dyspepsia patients before and after Helicobacter pylori eradication. (1998) (34)
Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, protects pancreas against acute cerulein-induced pancreatitis. (2005) (34)
Histamine in stress ulcer prophylaxis in rats. (2001) (34)
Opiates and the gastrointestinal tract. (1980) (34)
Effects of E, F, and I series prostaglandins and analogues on growth of gastroduodenal mucosa and pancreas. (1985) (34)
Effects of pirenzepine and atropine on gastric secretory and plasma hormonal responses to sham-feeding in patients with duodenal ulcer. (1980) (34)
Nitric oxide synthase inhibition and platelet function. (1994) (33)
Vagal cholinergic control of gastric alkaline secretion in normal subjects and duodenal ulcer patients. (1987) (33)
Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. (1995) (33)
Effect of human pancreatic polypeptide and its C-terminal hexapeptide on pancreatic secretion in man and in the dog. (1982) (33)
Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. (1995) (33)
Influence of capsaicin-sensitive afferent neurons and nitric oxide (NO) on cerulein-induced pancreatitis in rats (1996) (33)
Disturbed gastric motor activity in patients with human immunodeficiency virus infection. (1997) (33)
Release and action of epidermal growth factor on gastric secretion in humans. (1989) (33)
Release and action of epidermal growth factor on gastric secretion in humans. (1989) (33)
Effect of sensory nerves and CGRP on the development of caerulein-induced pancreatitis and pancreatic recovery. (2001) (33)
Influence of ghrelin on gastric and duodenal growth and expression of digestive enzymes in young mature rats. (2006) (33)
Vagal cholinergic control of gastric alkaline secretion in normal subjects and duodenal ulcer patients. (1987) (33)
Deleterious Effect of Helicobacter pylori Infection on the Course of Acute Pancreatitis in Rats (2011) (33)
Importance of nitric oxide and capsaicin-sensitive afferent nerves in healing of stress lesions induced by epidermal growth factor. (1997) (32)
Studies on the inhibition of pancreatic secretion by luminal somatostatin. (1981) (32)
The role of female and male sex hormones in the healing process of preexisting lingual and gastric ulcerations. (2004) (32)
Neural aspects of ghrelin-induced gastroprotection against mucosal injury induced by noxious agents. (2006) (32)
Gastric alkaline response to mucosa-damaging agents: effect of 16,16-dimethyl prostaglandin E2. (1981) (32)
Exogenous and endogenous cholecystokinin protects gastric mucosa against the damage caused by ethanol in rats. (1995) (31)
Lipopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide. (1997) (30)
Prostaglandins and vagal stimulation of gastric secretion in duodenal ulcer patients. (1983) (30)
Brain-gut and appetite regulating hormones in the control of gastric secretion and mucosal protection. (2008) (30)
Role of leptin in the stomach and the pancreas (2001) (30)
Direct inhibition of gastric secretion and mucosal blood flow by arachidonic acid. (1979) (30)
Gastric secretion and the pathogenesis of peptic ulcer in the Helicobacter pylori infection. (1996) (30)
Agonist of peroxisome proliferator-activated receptor gamma (PPAR-γ: A new compound with potent gastroprotective and ulcer healing properties (2005) (30)
Relationships between duodenal motility and pancreatic secretion in fasted and fed dogs. (1986) (30)
Role of growth factors in gastroduodenal protection and healing of peptic ulcers. (1990) (30)
Comparison of cholecystokinin, pentagastrin, and duodenal oleate in gastroprotection in rats. (1995) (30)
Gastric secretion and the pathogenesis of peptic ulcer in the Helicobacter pylori infection. (1996) (30)
Localization of the Mechanism for Inhibition of Gastric Secretion by Acid in Intestine (1965) (30)
Expression of constitutive nitric oxide synthase in rat and human gastrointestinal tract. (1999) (30)
Nocloprost, a unique prostaglandin E2 analog with local gastroprotective and ulcer-healing activity. (1991) (29)
Modulation of pancreatic enzyme secretion by melatonin and its precursor; L-tryptophan. Role of CCK and afferent nerves. (2004) (29)
Endocrine, Gastrointestinal, and Antitumor Activity of Somatostatin Analogues (1986) (29)
Epidermal Growth Factor Protects against Pancreatic Damage in Cerulein-Induced Pancreatitis (1999) (29)
Localization of cholecystokinin release in intestine of the dog. (1972) (29)
Role of circadian rhythm and endogenous melatonin in pathogenesis of acute gastric bleeding erosions induced by stress. (2007) (29)
Leptin in the control of gastric secretion and gut hormones in humans infected with Helicobacter pylori. (2001) (29)
Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on gastric motility in duodenal ulcer patients. (2001) (29)
Perspectives of anti-H.pylori vaccination (1997) (29)
Role of nitric oxide and prostaglandins in sucralfate-induced gastroprotection. (1992) (29)
Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on gastric motility in duodenal ulcer patients. (2001) (29)
Hormonal protection in acute pancreatitis by ghrelin, leptin and melatonin. (2014) (29)
Leptin in the control of gastric secretion and gut hormones in humans infected with Helicobacter pylori. (2001) (29)
Gastrointestinal secretory, motor and circulatory effects of corticotropin releasing factor (CRF). (1985) (28)
Melatonin precursor; L-tryptophan protects the pancreas from development of acute pancreatitis through the central site of action. (2004) (28)
Ischemic preconditioning reduces the severity of ischemia/reperfusion-induced pancreatitis. (2003) (28)
Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines. (2011) (28)
Increase of heat shock protein gene expression by melatonin in AR42J cells. (2005) (28)
Comparison of effects of neurotensin and fat on pancreatic stimulation in dogs. (1983) (28)
Heat shock protein 70 (HSP70) in gastric adaptation to aspirin in Helicobacter pylori infection. (2001) (28)
Influence of extremely-low-frequency magnetic field on antioxidative melatonin properties in AT478 murine squamous cell carcinoma culture (2007) (28)
Comparison of amino acids bathing the oxyntic gland area in the stimulation of gastric secretion. (1976) (28)
Heat shock protein 70 (HSP70) in gastric adaptation to aspirin in Helicobacter pylori infection. (2001) (28)
Role of nitric oxide in gastroduodenal alkaline secretion. (1994) (28)
Comparison of telenzepine, pirenzepine and atropine on gastric acid and pepsin secretion in response to histamine, pentagastrin, bethanechol, sham-feeding and feeding. (1989) (27)
The effect of luminal ghrelin on pancreatic enzyme secretion in the rat (2007) (27)
Role of sensory nerves in pancreatic secretion and caerulein-induced pancreatitis. (1997) (27)
Role of cholecystokinin in the inhibition of gastric acid secretion in dogs. (1992) (27)
Detection of Specific Helicobacter pylori DNA and Antigens in Stool Samples in Dyspeptic Patients and Healthy Subjects (2002) (27)
Role of gastrin and cholecystokinin in the growth-promoting action of bombesin on the gastroduodenal mucosa and the pancreas (1990) (27)
Role of leukotrienes and platelet activating factor in acute gastric mucosal lesions in rats. (1989) (27)
Biomarkers in Various Types of Atrophic Gastritis and Their Diagnostic Usefulness (2005) (27)
Brain-gut axis in the modulation of pancreatic enzyme secretion. (2010) (27)
Effect of ischemic preconditioning on pancreatic regeneration and pancreatic expression of vascular endothelial growth factor and platelet-derived growth factor-A in ischemia/reperfusion-induced pancreatitis. (2006) (26)
Sensory nerves and calcitonin gene related peptide in the effect of ischemic preconditioning on acute and chronic gastric lesions induced by ischemia-reperfusion. (2001) (26)
Role of leptin in the control of postprandial pancreatic enzyme secretion. (2003) (26)
Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients. (1996) (26)
Epidermal growth factor accelerates pancreatic recovery after caerulein-induced pancreatitis. (2000) (26)
Impact of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on gastric ulcerogenesis in experimental animals and in humans. (2002) (26)
Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients. (1996) (26)
Gastric electromechanical dysfunction in Parkinson's disease. (2000) (26)
Tryptophan free diet delays healing of chronic gastric ulcers in rat. (2008) (26)
Role of GIP and insulin in glucose-induced changes in intestinal motility patterns. (1987) (26)
Impact of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on gastric ulcerogenesis in experimental animals and in humans. (2002) (26)
Gastroprotection and control of food intake by leptin. Comparison with cholecystokinin and prostaglandins. (1999) (26)
Effect of enkephalin and naloxone on gastric acid and serum gastrin and pancreatic polypeptide concentrations in humans. (1983) (26)
Implication of gastrin in cyclooxygenase-2 expression in Helicobacter pylori infected gastric ulceration. (2001) (26)
Role of GIP and insulin in glucose-induced changes in intestinal motility patterns. (1987) (26)
Acceleration of wound healing in gastric ulcers by local injection of neutralising antibody to transforming growth factor beta 1. (1996) (25)
Effects of somatostatin-14 and somatostatin-28 on plasma hormonal and gastric secretory responses to cephalic and gastrointestinal stimulation in man. (1985) (25)
Prostacyclin-Induced Gastric Mucosal Vasodilation and Inhibition of Acid Secretion in the Dog (1980) (25)
Comparison of intravenous amino acids in the stimulation of gastric secretion (1978) (25)
Mechanisms of gastroprotection. (1990) (25)
Helicobacter pylori from duodenal ulcer patients expresses inducible nitric oxide synthase immunoreactivity in vivo and in vitro. (1996) (25)
Effect of thyrotropin-releasing hormone on gastro-intestinal secretions in dogs. (1981) (25)
Helicobacter pylori from duodenal ulcer patients expresses inducible nitric oxide synthase immunoreactivity in vivo and in vitro. (1996) (25)
Action of omeprazole (a benzimidazole derivative) on secretory responses to sham feeding and pentagastrin and upon serum gastrin and pancreatic polypeptide in duodenal ulcer patients. (1984) (25)
Role of endogenous prostaglandins in duodenal alkaline response to luminal hydrochloric acid or arachidonic acid in conscious dogs. (1986) (25)
Role of endogenous prostaglandins in duodenal alkaline response to luminal hydrochloric acid or arachidonic acid in conscious dogs. (1986) (25)
New satiety hormone nesfatin-1 protects gastric mucosa against stress-induced injury: Mechanistic roles of prostaglandins, nitric oxide, sensory nerves and vanilloid receptors (2013) (25)
Duodenal alkaline secretion: its mechanisms and role in mucosal protection against gastric acid. (2004) (25)
Effect of vitamin C-releasing acetylsalicylic acid on gastric mucosal damage before and after Helicobacter pylori eradication therapy. (2004) (24)
Effect of secretin and jejunal acidification on gastric and pancreatic secretion in man (1970) (24)
Omentum and basic fibroblast growth factor in healing of chronic gastric ulcerations in rats (1994) (24)
Protective role of endogenous nitric oxide (NO) in lipopolysaccharide--induced pancreatic damage (a new experimental model of acute pancreatitis). (2000) (24)
Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man. (1990) (24)
Effect of vitamin C-releasing acetylsalicylic acid on gastric mucosal damage before and after Helicobacter pylori eradication therapy. (2004) (24)
Helicobacter pylori inhibits expression of heat shock protein 70 (HSP70) in human epithelial cell line. Importance of Cag A protein. (2006) (24)
The Mechanism of Heat‐Shock Protein 70 Gene Expression Abolition in Gastric Epithelium Caused by Helicobacter pylori Infection (2006) (24)
Generation of prostaglandins in gastric mucosa of patients with peptic ulcer disease: effect of nonsteroidal antiinflammatory compounds. (1984) (24)
Mechanisms of Gastroprotection (1990) (24)
Neuroendocrinology of gastric H+ and duodenal HCO3- secretion: the role of brain-gut axis. (2004) (24)
Nitric Oxide Releasing Aspirin Protects the Gastric Mucosa against Stress and Promotes Healing of Stress-Induced Gastric Mucosal Damage: Role of Heat Shock Protein 70 (2002) (24)
Gastric adaptation to stress: role of sensory nerves, salivary glands, and adrenal glands. (1995) (24)
Melatonin and its precursor L-tryptophan prevent acute gastric mucosal damage induced by aspirin in humans. (2008) (23)
Effect of somatostatin on gastrointestinal secretions and peptic ulcer production in cats. (1977) (23)
Melatonin and its precursor L-tryptophan prevent acute gastric mucosal damage induced by aspirin in humans. (2008) (23)
Prostacyclin inhibits pancreatic secretion. (1980) (23)
Mucosal irritation, adaptive cytoprotection, and adaptation to topical ammonia in the rat stomach. (1996) (23)
Effects of colloidal bismuth subcitrate on aspirin-induced gastric microbleeding, DNA loss, and prostaglandin formation in humans. (1988) (23)
Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines. (2011) (23)
Inhibition of cyclooxygenase-2 reduces the protective effect of hepatocyte growth factor in experimental pancreatitis. (2004) (22)
Effect of central and peripheral actions of histamine and its metabolite N-alpha methyl histamine on gastric secretion and acute gastric lesions. (2001) (22)
Role of histamine H1- and H2-receptors in myoelectric activity of small bowel in the dog. (1980) (22)
The effect of exogenous and endogenous secretin and cholecystokinin on pancreatic secretion in cats. (1971) (22)
Nitric oxide in gastroprotection by aluminium-containing antacids. (1992) (22)
Antagonism of receptors for bombesin, gastrin and cholecystokinin in pancreatic secretion and growth. (1991) (22)
The role of CGRP and afferent nerves in the modulation of pancreatic enzyme secretion in the rat (1997) (22)
Effect of vasoactive intestinal peptide on gastric secretion in the cat. (1982) (22)
Cholecystokinin in the regulation of gastric acid and endocrine pancreatic secretion in humans. (1993) (22)
Leptin is able to stimulate pancreatic enzyme secretion via activation of duodeno-pancreatic reflex and CCK release. (2004) (22)
Pancreatic polypeptide and vagal stimulation of gastric and pancreatic secretion in dogs. (1981) (22)
Gastric mucosal protection by agents altering gastric mucosal sulfhydryls. Role of endogenous prostaglandins. (1987) (22)
Effects of peripherally and centrally applied ghrelin in the pathogenesis of ischemia-reperfusion induced injury of the small intestine. (2011) (22)
Potentiation between pentapeptide (ICI 50123) and histamine in the stimulation of gastric secretion in man. (1967) (22)
Cholecystokinin in the regulation of gastric acid and endocrine pancreatic secretion in humans. (1993) (22)
The effects of antagonists of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas. (1991) (21)
Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs. (1989) (21)
Characteristics of intestinal phase of gastric secretion. (1976) (21)
Angiogenesis: quantitative assessment by the chick chorioallantoic membrane assay. (1988) (21)
Effect of exogenous and endogenous secretin on gastric and pancreatic secretion in cats. (1969) (21)
The influence of epidermal growth factor on the course of ischemia-reperfusion induced pancreatitis in rats. (2002) (21)
Gastric preconditioning induced by short ischemia: the role of prostaglandins, nitric oxide and adenosine. (2001) (21)
The Usefulness of Capsulated 13C-Urea Breath Test in Diagnosis of Helicobacter pylori Infection in Patients With Upper Gastrointestinal Bleeding (2003) (21)
Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs. (1989) (21)
Ischemic preconditioning inhibits development of edematous cerulein-induced pancreatitis: involvement of cyclooxygenases and heat shock protein 70. (2005) (21)
Platelet activating factor (PAF) inhibitor (TCV-309) reduces caerulein- and PAF-induced pancreatitis. A morphologic and functional study in the rat. (1992) (21)
Stimulation of sensory nerves and CGRP attenuate pancreatic damage in ischemia/reperfusion induced pancreatitis. (2003) (21)
Ultrasound-guided biopsies of abdominal organs with an automatic biopsy system. A retrospective analysis of the quality of biopsies and of hemorrhagic complications. (2000) (20)
Ghrelin in diseases of the gastric mucosa associated with Helicobacter pylori infection. (2010) (20)
Gastric adaptation: basic and clinical aspects. (1994) (20)
Functional and morphological aspects of Helicobacter pylori‐induced gastric cancer in Mongolian gerbils (2003) (20)
Influence of plant-originated gastroproteciive and antiulcer substances on gastric mucosal repair. (2004) (20)
Role of cholecystokinin in the intestinal fat- and acid-induced inhibition of gastric secretion (1992) (20)
Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines. (2014) (20)
Pentapeptide infusion test. (1967) (20)
Gastric adaptation: basic and clinical aspects. (1994) (20)
Adaptation of the gastric mucosa to stress. Role of prostaglandin and epidermal growth factor. (1992) (20)
Physiological role of cholecystokinin in gastroprotection in humans (1998) (20)
Comparison of pancreatic responses to portal and systemic secretin and VIP in cats. (1977) (20)
Physiological role of cholecystokinin in gastroprotection in humans (1998) (20)
Gastric adaptation to aspirin and stress enhances gastric mucosal resistance against the damage by strong irritants. (1996) (20)
Comparison of prostacyclin and prostaglandin E2 on gastric secretion, gastrin release, and mucosal blood flow in dogs (1980) (20)
Effect of atropine on gastrin and gastric acid response to peptone meal. (1974) (20)
Gastric acid does drive pancreatic bicarbonate secretion. (1974) (20)
Comparison of organ uptake and disappearance half-time of human epidermal growth factor and insulin (1990) (20)
Effect of exercise on gastrointestinal secretions. (1973) (20)
The Effect of Fat on Secretin Release (1978) (19)
Effect of 13‐NLE‐motilin on gastric secretion, serum gastrin level and mucosal blood flow in dogs. (1977) (19)
Chemical stimulatory mechanism in gastric secretion. (1975) (19)
Gastric secretion, proinflammatory cytokines and epidermal growth factor (EGF) in the delayed healing of lingual and gastric ulcerations by testosterone (2008) (19)
Effect of orally administered 15(R)-15-methyl prostaglandin E2 and/or an anticholinergic drug on meal-induced gastric acid secretion and serum gastrin level in patients with duodenal ulcers. (1979) (19)
The role of capsaicin-sensitive sensory neurons and nitric oxide in regulation of gastric mucosal growth. (1995) (19)
Effect of different muscle shortening velocities during prolonged incremental cycling exercise on the plasma growth hormone, insulin, glucose, glucagon, cortisol, leptin and lactate concentrations. (2002) (19)
Endotoxemia in newborn rats attenuates acute pancreatitis at adult age. (2007) (19)
Gastric cytoprotection by pirenzepine. Role of endogenous prostaglandins. (1982) (19)
Epidermal growth factor in gastric ulcer healing by nocloprost, a stable prostaglandin E2 derivative. (1997) (19)
Epidermal growth factor in gastric ulcer healing by nocloprost, a stable prostaglandin E2 derivative. (1997) (19)
Comparison of intraduodenal and intravenous administration of amino acids on gastric secretion in healthy subjects and patients with duodenal ulcer. (1978) (19)
The effect of cholinergic and adrenergic blockage on basal and pentagastrin-induced acid secretion. (1969) (19)
Ebrotidine, a novel H2-receptor antagonist with local gastroprotective activity (1991) (19)
Luminal Nalpha-methyl histamine stimulates gastric acid secretion in duodenal ulcer patients via releasing gastrin. (2001) (19)
The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines. (2016) (18)
Calcitonin gene-related peptide can attenuate or augment pancreatic damage in caerulein-induced pancreatitis in rats. (1999) (18)
Neurohormonal control of pancreatic secretion. (1974) (18)
SU-840, a novel synthetic flavonoid derivative of sophoradin, with potent gastroprotective and ulcer healing activity. (1998) (18)
Mucus glycoprotein secretion by duodenal mucosa in response to luminal arachidonic acid. (1986) (18)
Effects of omeprazole, a substituted benzimidazole, on gastrointestinal secretions, serum gastrin, and gastric mucosal blood flow in dogs. (1984) (18)
Gastric cytoprotection by acetazolamide: role of endogenous prostaglandins. (1983) (18)
Effects of protective drugs on gastric alkaline secretion in man. (1987) (18)
Effect of pH of gastric and intestinal meals on gastric acid and plasma gastrin and secretin responses in the dog. (1977) (18)
Role of afferent nerves and sensory peptides in the mediation of hepatic artery buffer response. (2003) (18)
Effects of peptide YY on dog and rat pancreatic secretion in vivo and in vitro (1988) (18)
Effects of omeprazole, a substituted benzimidazole, on gastrointestinal secretions, serum gastrin, and gastric mucosal blood flow in dogs. (1984) (18)
Effect of acid infusion into various levels of the intestine on gastric and pancreatic secretion in the cat (1969) (18)
Influence of substance P on myoelectric activity of the small bowel. (1982) (18)
Gastric analysis with fractional test meals (ethanol, caffeine, and peptone meal), augmented histamine or pentagastrin tests, and gastric pH recording. (2003) (18)
Cephalic phase of pancreatic secretion (2000) (17)
Role of Helicobacter pylori infection in gastro-duodenal secretion and in pathogenesis of peptic ulcer and gastritis. (1994) (17)
Nitric oxide and the interrelation between intestinal motility and pancreatic secretion in fasted and fed dogs. (1994) (17)
Effect of methylated prostaglandin E2 analogue on insulin secretion in man. (1978) (17)
Gastric mucosal expression and luminal release of growth factors in gastric carcinoma and duodenal ulcer patients before and after eradication of Helicobacter pylori. (1997) (17)
Melatonin stimulates HSP27 phosphorylation in human pancreatic carcinoma cells (PANC-1). (2007) (17)
Ghrelin and gastrin in advanced gastric cancer before and after gastrectomy. (2011) (17)
Prostaglandins in peptic ulcer disease: effect of nonsteroidal anti-inflammatory compounds (NOSAC). (1984) (17)
Effect of metiamide, a histamine H2-receptor antagonist, on gastric response to histamine, pentagastrin, insulin, and peptone meal in man (1974) (17)
Prostaglandin E2 in gastric mucosa and its role in the prevention of ulcers induced by acetyl salicylic acid in cats. (1981) (17)
Helicobacter pylori and impaired gastric secretory functions associated with duodenal ulcer and atrophic gastritis. (1997) (17)
Effect of Helicobacter pylori on delay in ulcer healing induced by aspirin in rats. (2002) (17)
Studies on gastroprotection induced by capsaicin and papaverine. (1992) (17)
Adaptation of gastric mucosa to stress. Effect of ranitidine. (1998) (17)
Expression of transforming growth factor-beta 1 and epidermal growth factor in caerulein-induced pancreatitis in rat. (1997) (17)
Gastric MALT-lymphoma, gastrin and cyclooxygenases. (2002) (17)
Effects of motilin on gastric and pancreatic secretion in dogs. (1976) (17)
Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients. (1995) (17)
Cholecystokinin in the control of gastric acid secretion in man. (1993) (17)
Cephalic phase of pancreatic secretion (2000) (17)
Cholecystokinin in the control of gastric acid secretion in man. (1993) (17)
Prevalence and characterization of Helicobacter pylori (H. pylori) infection and colonization in dentists. (2009) (17)
Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients. (1995) (17)
Gastric protection by meciadanol (1986) (17)
Somatostatin and gastrointestinal secretion and motility. (1978) (17)
Gastroprotection by sucralfate against acetylsalicylic acid in humans. Role of endogenous prostaglandins. (1987) (16)
The correlation between gastric acid secretion and histology of fundic and antral gland area. (1969) (16)
Esophagoprotection mediated by exogenous and endogenous melatonin in an experimental model of reflux esophagitis (2013) (16)
Gastric acid and pancreatic polypeptide responses to modified sham feeding. Effects of truncal and parietal cell vagotomy. (1987) (16)
Serum Progastrin and Its Products, Gastric Acid Secretion and Serum Pepsinogen I in Gastric Cancer (2004) (16)
Inhibition by secretin of the gastric acid responses to meals and to pentagastrin in duodenal ulcer patients (1973) (16)
Involvement of sensory afferent fibers and lipid peroxidation in the pathogenesis of stress-induced gastric mucosa damage. (2007) (16)
Progastrin and its products from patients with chronic viral hepatitis and liver cirrhosis. (2003) (16)
Role of β-Adrenoceptors in Gastric Mucosal Integrity and Gastroprotection Induced by Epidermal Growth Factor (1997) (16)
Comparison of helodermin, VIP and PHI in pancreatic secretion and blood flow in dogs (1989) (16)
Involvement of orexigenic peptides in the mechanism of gastric mucosal integrity and healing of chronic gastric ulcers. (2010) (16)
Gastric mucosal damage and adaptive protection by ammonia and ammonium ion in rats. (1996) (16)
Role of tachykinins in the control of pancreatic secretion and circulation. (1992) (16)
Effect of exclusion, acidification, and excision of the duodenum on gastric acid secretion and the production of pentagastrin-induced peptic ulcers in cats. (1969) (16)
Dynamics of gastric acid inhibition by ranitidine in duodenal ulcer patients. (1981) (15)
Role of neutrophils and mucosal blood flow in gastric adaptation to aspirin. (1994) (15)
Effect of calcitonin on gastric and pancreatic secretion and peptic ulcer formation in cats (1974) (15)
Role of secretin and CCK in the stimulation of pancreatic secretion in conscious dogs. Effects of atropine and somatostatin (1987) (15)
Influence of Tołpa Peat Preparation on gastroprotection and on gastric and duodenal ulcers. (1994) (15)
Comparison of the effect of omeprazole--a substituted benzimidazole--and ranitidine--a potent H2-receptor antagonist--on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells. (1983) (15)
Stimulation of gastrin release and gastric secretion by amino acids bathing pyloric gland area. (1977) (15)
Effect of neonatal endotoxemia on the pancreas of adult rats. (2008) (15)
Enhanced Resistance of Gastric Mucosa to Damaging Agents in the Rat Stomach Adapted to Helicobacter pylori Lipopolysaccharide (2003) (15)
Leptin is the modulator of HSP60 gene expression in AR42J cells. (2006) (15)
Nitric oxide-releasing aspirin protects gastric mucosa against ethanol damage in rats with functional ablation of sensory nerves (2003) (15)
Comparison of the effect of omeprazole--a substituted benzimidazole--and ranitidine--a potent H2-receptor antagonist--on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells. (1983) (15)
Role of endogenous nitric oxide in the control of exocrine and endocrine pancreatic secretion. (1995) (15)
Central and peripheral neural aspects of gastroprotective and ulcer healing effects of lipopolysaccharides. (2001) (15)
Role of secretin and CCK in the stimulation of pancreatic secretion in conscious dogs. Effects of atropine and somatostatin (1987) (15)
Effect of atropine on pancreatic responses to endogenous and exogenous cholecystokinin (1972) (15)
Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils. (2003) (15)
Incidence of complications of peptic ulcers in patients with Helicobacter pylori (Hp) infection and/or NSAID use in the era of Hp eradication. (2002) (14)
Duodenal mechanisms for inhibition of gastric acid secretion in the dog. (1971) (14)
Effects of leukotrienes on gastric acid and alkaline secretions. (1987) (14)
Effect of somatostatin on the growth of gastrointestinal mucosa and pancreas in rats. Role of endogenous gastrin. (1987) (14)
Comparison of TRH and anorexigenic peptide on food intake and gastrointestinal secretions (1981) (14)
Effect of glucagon on food-induced gastrointestinal secretions. (1973) (14)
Comparison effects of metiamide and atropine on gastric and pancreatic secretion and peptic ulcer formation in cat. (1974) (14)
Transforming growth factor-alpha binds to the epidermal growth factor receptor in gastric mucosa. (1991) (14)
Effect of diversion and replacement of bile on pancreatic secretion (1973) (14)
Gastric secretion--from Pavlov's nervism to Popielski's histamine as direct secretagogue of oxyntic glands. (2003) (13)
The importance of gastric secretion in the feedback control of interdigestive and postprandial pancreatic secretion in rats (1991) (13)
Molecular mechanism of protection against chemically and gamma-radiation induced apoptosis in human colon cancer cells. (2008) (13)
Ischemic preconditioning of the hindlimb or kidney does not attenuate the severity of acute ischemia/reperfusion-induced pancreatitis in rats. (2008) (13)
Luminal melatonin stimulates pancreatic enzyme secretion via activation of serotonin-dependent nerves. (2013) (13)
Involvement of central and peripheral histamine H(3) receptors in the control of the vascular tone and oxygen uptake in the mesenteric circulation of the rat. (2004) (13)
The history of gastrointestinal hormones and the Polish contribution to elucidation of their biology and relation to nervous system. (2003) (13)
Gastric secretion and ulcer healing in mouse stomach infected with cytotoxin expressing strain of Helicobacter pylori. (1998) (13)
Role of acid milieu in the gastroprotective and ulcer-healing activity of sucralfate. (1991) (13)
Salivary and gastric luminal release of epidermal growth factor under basal conditions and after pentagastrin stimulation in healthy subjects and in duodenal ulcer patients before and after eradication of Helicobacter pylori. (1996) (13)
Microcirculatory and motor effects of endogenous nitric oxide in the rat gut. (1993) (13)
Disturbed gastric motility and pancreatic hormone release in diabetes mellitus. (1998) (13)
Vasoactive and metabolic effects of leukotriene C4 and D4 in the intestine. (1988) (13)
Stimuli for intestinal phase of gastric secretion in dogs. (1978) (13)
Comparison of enkephalin and atropine in the inhibition of vagally stimulated gastric and pancreatic secretion and gastrin and pancreatic polypeptide release in dogs (1982) (13)
Microdose 14C-urea breath test in detection of Helicobacter pylori. (1996) (13)
Effects of anorexigenic peptide on gastric and pancreatic secretion. (1981) (13)
Intragastric pH in the gastroprotective and ulcer-healing activity of aluminum-containing antacids. (1991) (13)
Involvement of vagal nerves in the pancreatostimulatory effects of luminal melatonin, or its precursor L-tryptophan. Study in the rats. (2007) (13)
Involvement of ornithine decarboxylase and polyamines in epidermal growth factor-induced recovery of gastric mucosa from gastric lesions provoked by stress (1998) (13)
Helicobacter pylori infection after gastrectomy and vagotomy in duodenal ulcer patients. (1996) (13)
Cyclic-AMP and Pancreatic Bicarbonate Secretion in Response to Secretin in Dogs (1975) (12)
Role of cholecystokinin, gastrin and gastrin-releasing peptide in the regulation of pancreatic secretion in cats. (1991) (12)
Interaction of Helicobacter pylori (Hp) and nonsteroidal anti-inflammatory drugs (NSAID) on gastric mucosa and risk of ulcerations. (2002) (12)
Pancreatic bicarbonate, serum gastrin, and secretin responses to meals varying in pH. (1977) (12)
The influence of gastrin-related peptides on HCl secretion in man and in cats with gastric fistulas and Heidenhain pouches. (1966) (12)
Cholecystokinin receptor antagonism by peptidergic and non‐peptidergic agents in rat pancreas. (1989) (12)
ENDOGENOUS NITRIC OXIDE IN THE REGULATION OF GASTRIC ACID SECRETION, GASTRIN RELEASE AND BLOOD FLOW (1994) (12)
Inhibitory effect of EGF on secretory response of rat parietal cells is associated with an induction of ODC. (1993) (12)
Effects of Sucralfate on Growth Factor Availability (1995) (12)
Effects of Sucralfate on Growth Factor Availability (1995) (12)
Evaluation of urinary 6-hydroxymelatonin sulphate excretion in women at different age with irritable bowel syndrome. (2010) (12)
Only live Helicobacter pylori is capable of caspase-3 dependent apoptosis induction in gastric mucosa epithelial cells. (2009) (12)
Role of Helicobacter pylori infection in gastro-duodenal secretion and in pathogenesis of peptic ulcer and gastritis. (1994) (12)
mRNA expression of EGF receptor ligands in atrophic gastritis before and after Helicobacter pylori eradication. (2002) (12)
Subserosal application of transforming growth factor-beta 1 in rats with chronic gastric ulcers: effect on gastric ulcer healing and blood flow. (1996) (12)
The effect of exercise performed before and 24 hours after blood withdrawal on serum erythropoietin and growth hormone concentrations in humans. (2003) (12)
mRNA expression of EGF receptor ligands in atrophic gastritis before and after Helicobacter pylori eradication. (2002) (12)
Inhibition of pancreatic secretion by enkephalin and morphine in dogs. (1978) (12)
The use of carprofen, a non-steroidal antiinflammatory agent, in peptic ulcer diseases. (1983) (12)
Gastric cytoprotection. (1985) (12)
Differential effects of prostaglandins and arachidonic acid on gastric circulation and oxygen consumption. (1980) (11)
Role of prostaglandins in intestinal secretion, motility, and circulation. (1985) (11)
Gastric wall perforation: a rare complication of gastric electrical stimulation. (2004) (11)
Effect of diversion of bile and pancreatic juice on pentagastrin-produced duodenal ulcers in cats. (1969) (11)
Nitric oxide in gastroprotective and ulcer healing effects of sucralfate. (1995) (11)
Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori. (1994) (11)
Gastric cytoprotection by agents altering gastric mucosal sulfhydryl compounds: role of endogenous prostaglandins. (1983) (11)
Comparison of sucralfate and ranitidine in gastroprotection against alcohol in humans. (1989) (11)
Intracerebroventricular administration of bacterial lipopolysaccharide prevents the development of acute experimental pancreatitis in the rat. (2002) (11)
Inhibition of gastric secretion by fat and hypertonic glucose in the dog: role of gastric inhibitory peptide. (1983) (11)
The efficacy of hydrotalcite compared with OTC famotidine in the on-demand treatment of gastroesophageal reflux disease: a non-inferiority trial. (2006) (11)
Effect of acetylsalicylic acid on the constituents of the gastric mucosal barrier. (1984) (11)
Role of prostaglandins in intestinal secretion, motility, and circulation. (1985) (11)
Release and binding of epidermal growth factor in the pancreas of rats (1992) (11)
Polyamines and epidermal growth factor in the recovery of gastric mucosa from stress-induced gastric lesions. (1998) (11)
Effect of synthetic 15-methyl analog of prostaglandin E2 on gastric secretion and peptic ulcer formation. (1974) (11)
The influence of cholecystokinin on gastric myoelectrical activity in duodenal ulcer following Helicobacter pylori eradication--an electrogastrographic study. (2002) (11)
Cephalic phase of gastroduodenal alkaline secretion. (1986) (11)
Lipoxins, the novel mediators of gastroprotection and gastric adaptation to ulcerogenic action of aspirin. (2011) (11)
Gastric electrical stimulation for gastroparesis: A multi-center double blind cross over study, by the wavess study group (2000) (11)
Gastroprotective and antisecretory effects of ebrotidine. (1992) (11)
Effects of Nicotine on Gastric Secretion and Ulcer Formation in Cats 1 (1971) (11)
Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans. (1997) (11)
Comparison of sucralfate and ranitidine in gastroprotection against alcohol in humans. (1989) (11)
Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans. (1997) (11)
Comparison of vasoactive intestinal peptide (VIP) and secretin in gastric secretion and mucosal blood flow (1976) (11)
Gastroprotective and ulcer-healing activities of a new H2-receptor antagonist: ebrotidine. (1992) (11)
Effect of graded doses of pentagastrin, histamine and 2-deoxy-D-glucose on gastric secretion and motility in conscious rats. (1968) (11)
The history of gastrointestinal hormones and the Polish contribution to elucidation of their biology and relation to nervous system. (2003) (10)
Role of polyamines in gastroprotection induced by epidermal growth factor. (1991) (10)
Release of secretin and cholecystokinin in the duodenum and small intestine. (1972) (10)
Gastric secretion--from Pavlov's nervism to Popielski's histamine as direct secretagogue of oxyntic glands. (2003) (10)
Somatostatin and the gastrointestinal secretions. (1976) (10)
Role of gastric antrum in gastric and intestinal phases of gastric secretion in dogs. (1979) (10)
Growth Factors in Gastric Mucosal Integrity, Protection and Healing of Acute and Chronic Ulcerations (1993) (10)
Enhancement in the protective qualities of gastric mucus with combination therapy of ebrotidine and amoxicillin for H. pylori eradication. (1998) (10)
Role of cholecystokinin in the control of gastric acid secretion and gastrin release in dogs and healthy and duodenal ulcer subjects. (1993) (10)
[Intraductal ultrasound in the pancreaticobiliary duct system]. (2008) (10)
Water Extracts of Helicobacter pylori Suppress the Expression of Histidine Decarboxylase and Reduce Histamine Content in the Rat Gastric Mucosa (2000) (10)
Adaptation of pancreas to repeated caerulein-induced pancreatitis in rats. (1996) (10)
The influence of sensory nerves and CGRP on the pancreatic regeneration after repeated episodes of acute pancreatitis in rats. (2000) (10)
Effect of glucagon on gastric and pancreatic secretion and peptic ulcer formation in cats (2005) (10)
Gastric mucosal blood flow and neutrophil activation in aspirin-induced gastric mucosal damage in man. (1993) (10)
Decreased expression of epidermal growth factor receptor and mRNA of its ligands in Helicobacter pylori-infected gastric mucosa. (2001) (10)
Role of cholecystokinin in the control of gastric acid secretion and gastrin release in dogs and healthy and duodenal ulcer subjects. (1993) (10)
Nitric oxide is involved in the mediation of gastric blood flow and tissue oxygenation. (1994) (10)
Importance of an acid milieu in the sucralfate-induced gastroprotection against ethanol damage. (1989) (10)
Growth Factors in Gastric Mucosal Integrity, Protection and Healing of Acute and Chronic Ulcerations (1993) (10)
Intestinal phase of gastric secretion in patients with duodenal ulcer (1978) (10)
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients. (1996) (10)
Inhibition of acid secretory response and induction of ornithine decarboxylase and its mRNA by TGFα and EGF in isolated rat gastric glands (1995) (10)
Urea-urease system in cytoprotection against acute mucosal damage. (1996) (10)
Effects of somatostatin on intestinal circulation and oxygen consumption. (1989) (10)
Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients. (1981) (10)
Gastroprotective and ulcer healing effects of solon, a synthetic flavonoid derivative of sophoradin. (1987) (10)
Case presentation of gastrinoma combined with gastric carcinoid with the longest survival record -- Zollinger-Ellison syndrome: pathophysiology, diagnosis and therapy. (2002) (9)
Gastroprotection by an aluminium- and magnesium hydroxide-containing antacid in rats. Role of endogenous prostanoids. (1989) (9)
Valosin stimulates gastric and exocrine pancreatic secretion and inhibits fasting small intestinal myoelectric activity in the dog. (1987) (9)
Case presentation of gastrinoma combined with gastric carcinoid with the longest survival record -- Zollinger-Ellison syndrome: pathophysiology, diagnosis and therapy. (2002) (9)
Generation of endogenous prostaglandins and thromboxanes in taurocholate-induced gastric mucosal lesions. (1984) (9)
Antagonism of histamine H2-receptors and gastric secretion. (1973) (9)
Release of Antral and Duodenal Gastrin in Response to an Intestinal Meal (1977) (9)
Role of Cholecystokinin in Gallbladder and Duodenal Motility in the Interdigestive State of Dogs (1990) (9)
The role of epidermal growth factor in platelet-endothelium interactions. (1998) (9)
Valosin stimulates gastric and exocrine pancreatic secretion and inhibits fasting small intestinal myoelectric activity in the dog. (1987) (9)
Healing of chronic gastroduodenal ulcerations by antacids (1990) (9)
Comparison of intravenous amino acids in the stimulation of gastric secretion. (1978) (9)
Implications of nitric oxide in the action of cytoprotective drugs on gastric mucosa. (1993) (9)
Prostaglandins in pathophysiology of peptic ulcer disease (1985) (9)
Organ removal and disappearance half-time of synthetic human pancreatic polypeptide. (1982) (9)
Mechanisms of the inhibitory action of prostaglandins on meal-induced gastric secretion. (1978) (9)
Effects of pirenzepine and atropine on amylase response to various secretagogues from the rat pancreatic acini. (1987) (9)
Carprofen and the therapy of gastroduodenal ulcerations by ranitidine. (1985) (9)
Effects of ebrotidine on aspirin-induced gastric mucosal damage and blood flow in humans. (1993) (9)
The effects of ammonia on pancreatic enzyme secretion in vivo and in vitro. (2000) (9)
Influence of central and peripheral administration of pancreatic polypeptide on gastric mucosa growth. (2004) (8)
Ebrotidine : A viewpoint. Commentary's (1996) (8)
Role of intragastric pH in cytoprotection by antacids in rats. (1990) (8)
Relationship between ghrelin and Helicobacter pylori infection in Polish adult shepherds and their children (2006) (8)
Comparison of natural and synthetic prostaglandins on gastric and pancreatic secretions and peptic ulcer formation in conscious cats. (1976) (8)
Adaptive cytoprotection by ammonia and urea-urease system in the rat gastric mucosa. (1995) (8)
Nitric oxide in gastroprotection by sucralfate, mild irritant, and nocloprost (1994) (8)
Cholecystokinin (CCK) in the amino acid uptake and enzyme protein secretion by the pancreas in humans (1995) (8)
Comparison of endogenous release of secretin and cholecystokinin in proximal and distal duodenum in the dog. (1974) (8)
Effect of ranitidine, a new H2-antagonist, on gastric and pancreatic secretion in duodenal ulcer patients (1980) (8)
[Secretory mechanisms of digestive glands]. (1976) (8)
Brain-gut axis in gastrointestinal system: Introductory remarks (2003) (8)
Reduced expression of Ca2+-regulating proteins in the upper gastrointestinal tract of patients with achalasia. (2006) (8)
Effects of leukotriene C4 on pancreatic secretion and circulation in dogs. (1988) (8)
Helicobacter pylori-positive peptic ulcer patients do not adapt to aspirin. (1998) (8)
Cholecystokinin (CCK) in the amino acid uptake and enzyme protein secretion by the pancreas in humans (1995) (8)
Exposition of newborn rats to bacterial endotoxin impairs pancreatic enzyme secretion at adult age. (2007) (8)
Aspirin effects on gastric epithelial cell proliferation and cytokine expression (2001) (8)
Cholinergic control of gastric acid secretion in man. (1982) (8)
Effect of Partial Versus Complete Pancreatic Denervation on Pancreatic Secretion (1987) (8)
Helicobacter pylori-positive peptic ulcer patients do not adapt to aspirin. (1998) (8)
Effect of atropine on pancreatic responses to endogenous and exogenous secretin (1971) (7)
Intestinal release of mucin in response to HCl and taurocholate: effect of indomethacin. (1987) (7)
Effect of enkephalin and naloxone on vagal and hormonal stimulation of pancreatic secretion in man. (1983) (7)
Effects of prostaglandin of E, F and I series, leukotriene C and platelet activating factor on amylase release from isolated rat pancreatic acini. (1993) (7)
Localization of secretin release by acid in small intestine of the dog. (1971) (7)
[Studies on the influence of Candida fungal colonization on the healing process of inflammatory lesions in the colon in rat animal model]. (2007) (7)
Effect of duodenal fat on plasma levels of gastrin and secretin and on gastric acid responses to gastric and intestinal meals in dogs (1978) (7)
Comparison of gastric and intestinal antisecretory and protective effects of prostacyclin and its stable thia-imino-analogue (Hoe 892) in conscious rats. (1984) (7)
Endotoxemia in the infant rats modulates HSP60 protein level in the pancreatic acinar cells. (2007) (7)
The role of vagal innervation in gastric and pancreatic responses to meals varying in pH (1974) (7)
Cephalic phase of gastroduodenal alkaline secretion. (1987) (7)
Role of histamine in ghrelin-induced gastroprotection against acute gastric lesions (2007) (7)
Physiological role of nitric oxide in gallbladder emptying in men. (1997) (7)
Gastroprotective activity and receptor expression of transforming growth factor alpha, epidermal growth factor and basic fibroblast growth factor in the rat stomach (1994) (7)
Solcoseryl in prevention of stress-induced gastric lesions and healing of chronic ulcers. (1991) (7)
Role of prostaglandin and thromboxane biosynthesis in gastric necrosis produced by taurocholate and ethanol (1983) (7)
The stomach : physiology, pathophysiology, and treatment (1993) (7)
The effect of secretin, gastrin-pentapeptide, and histamine on gastric acid and hepatic bile secretion in man (1969) (7)
Cholinergic control of gastric acid secretion in man. (1982) (7)
Physiological role of nitric oxide in gallbladder emptying in men. (1997) (7)
Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/ reperfusion in rat. (2003) (7)
Long-Lasting Effect of Infant Rats Endotoxemia on Heat Shock Protein 60 in the Pancreatic Acinar Cells: Involvement of Toll-Like Receptor 4 (2012) (7)
Characteristics of gastric inhibition by acidification of oxyntic gland area. (1975) (7)
The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas. (1991) (6)
Pancreatic polypeptide and intestinal motility in dogs (1987) (6)
Gastric vasoconstrictive and secretory effects of leukotrienes C4 and D4 in canine stomach. (1987) (6)
Effect of meciadanol on gastric secretion and aspirin-induced gastric mucosal injury in humans. (1984) (6)
Somatostatin and the digestive system. (1977) (6)
Gastrocytoprotec tion bycolloidal bismuth subcitrate (De-Nol) andsucralfate. Roleofendogenous prostaglandins (1987) (6)
Somatostatin and the digestive system. (1977) (6)
Vagal influence on gastrin and gastric acid responses to gastric and intestinal meals. (1977) (6)
Gastrin-like pentapeptide I.C.I. 50 123: A potent gastric stimulant in man (1967) (6)
[Effect of calcitonin on gastric and pancreatic secretion and on the formation of experimental peptic ulcers in cats (author's transl)]. (1974) (6)
Current concepts of neuro-hormonal control of pancreatic secretion (1978) (6)
Incidence of Chlamydia pneumoniae infection in patients with coronary artery disease subjected to angioplasty or bypass surgery. (2001) (6)
Cholecystokinin in the control of gastric acid secretion in humans (1992) (6)
Effect of caerulein on pentagastrin-induced gastric acid secretion and peptic ulcers in cats. (1970) (6)
Comparison of solcoseryl and epidermal growth factors (EGF) in healing of chronic gastroduodenal ulcerations and mucosal growth in rats. (1988) (6)
Multifocal atrophic gastritis: pathogenesis and therapeutic implications (2005) (6)
Pharmacologic control of gastric acid secretion in peptic ulcer. (1983) (6)
Involvement of gastrin in gastric secretory and protective actions of N-alpha-methyl histamine (2001) (6)
Pancreatic polypeptide and intestinal motility in dogs (1987) (6)
Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers. (2005) (6)
Involvement of Capsaicin-Sensitive Afferent Nerves and Cholecystokinin 2/Gastrin Receptors in Gastroprotection and Adaptation of Gastric Mucosa to Helicobacter pylori-Lipopolysaccharide (2004) (6)
A case of melatonin-induced biochemical flare in a patient with primary sclerosing cholangitis with features of autoimmune hepatitis (2019) (5)
Actions of novel bombesin receptor antagonists on pancreatic secretion in rats. (1992) (5)
Mesenteric lymph node Tγδ cells induced by gastrectomy in mice suppress cell-mediated immune response in vitro via released TGF-β (2007) (5)
Polyamines and growth factors in the recovery of gastric mucosa from stress-induced gastric lesions (1998) (5)
Gastric and pancreatic responses to meals varying in pH (1974) (5)
The significance of vagus nerves in the regulation of pancreatic secretion. (1974) (5)
Effect of medical vagotomy on acid and pepsin responses to histamine and pentagastrin in man. (1967) (5)
Comparison of Neurotensin and Fat on Myoelectric Activity Pattern of the Small Bowel (1984) (5)
Double-blind crossover study of ranitidine and ebrotidine in gastro-esophageal reflux disease. (1993) (5)
Comparison of Neurotensin and Fat on Myoelectric Activity Pattern of the Small Bowel (1984) (5)
Comparison of gastric inhibitory polypeptide and intraduodenal or intravenous fat on gastric acid secretion from vagally innervated and denervated canine stomach (2005) (5)
Role of neuropeptides in the control of gastric secretion. (1986) (5)
The influence of caerulein-like peptides on gastric secretion and peptic ulcer formation in cats. (1972) (5)
Effect of caerulein and endogenous cholecystokinin on urecholine-induced gastric acid and pancreatic protein secretion in dogs. (1973) (5)
Serological differentiation of Helicobacter pylori CagA(+) and CagA(-) infections. (2003) (5)
Comparison of gastric inhibitory polypeptide and intraduodenal or intravenous fat on gastric acid secretion from vagally innervated and denervated canine stomach (2005) (5)
7th Meeting of the Spanish Pancreatic Club / Author Index for Abstracts (2002) (5)
Role of New Appetite Hormones Ghrelin, Orexin-A and Obestatin in the Mechanism of Healing of Chronic Gastric Ulcers (2011) (5)
New aspects of clinical pharmacology of antacids. (1993) (5)
Napoleon Cybulski--Polish pioneer in developing of the device for measuring blood flow velocity. (2006) (5)
Systemic circulatory effects of pentagastrin. (1987) (5)
Effect of atropine on gastric acid response to graded doses of pentagastrin and histamine in duodenal ulcer patients before and after vagotomy (1968) (5)
Effect of 16,16-dimethyl prostaglandin E2 and ethanol on the constituents of gastric mucus. (1983) (5)
Drug-induced inhibition of gastric secretion. (1976) (5)
Immunoneutralization of Circulating Pancreatic Polypeptide and Pancreatic Secretion (1987) (5)
Prevention ofethanol andaspirin-induced gastric mucosal lesions byparacetamol andsalicylate inrats: role ofendogenous prostaglandins (1982) (5)
Histamine H3 receptors modulate reactive hyperemia in rat gut. (2004) (5)
Comparison of gastric and pancreatic inhibitory properties of metiamide and atropine. (1974) (4)
Efficacy of chronic gastric electrical stimulation in the treatment of symptomatic gastroparesis: Interim results at 6 and 12 months from a longitudinal, open-label study, the wavess study (2000) (4)
Effect of methylated PGE2 analogs given orally on pancreatic response to secretin in man (2005) (4)
Application of a diagnostic-therapeutic procedure using implant-supported dental prosthesis as a preventive therapy for candidiasis of upper gastrointestinal tract in complete denture users. (2008) (4)
MOMENTUM OMENTUM ! REPLY (1992) (4)
Gastroprotective and Ulcer Healing Properties of Bismuth Salts (1988) (4)
Antagonism of receptors for gastrin, cholecystokinin and GRP/bombesin in postprandial stimulation of exocrine pancreas in dogs. (1993) (4)
Pharmacology and clinical use of ranitidine. (1982) (4)
Base variant of human pancreatic secretory trypsin inhibitor in healing of stress-induced gastric lesions in rats (1998) (4)
Gastrin-like pentapeptide I.C.I. 50 123: A potent gastric stimulant in man (2005) (4)
Gastric acid, gastrin and pancreatic polypeptide responses to modified sham feeding in duodenal ulcer patients before and after highly selective or truncal vagotomy. (1990) (4)
Comparison of pancreatic responses to natural and synthetic secretins in conscious cats (1969) (4)
The effect of secretin on gastric Acid secretion and peptic ulcers induced by pentagastrin in cats with intact or resected duodenum (1968) (4)
Role of leukotrienes and platelet activating factor in gastric mucosal damage and repair. (1991) (4)
Efficacy and safety of ebrotidine compared with ranitidine in patients with duodenal ulcer. (1995) (4)
Effect of graded doses of pentagastrin, histamine and 2-deoxy-D-glucose on gastric secretion and motility in conscious rats. (1968) (4)
Stimulation of biliary secretion by duodenal acidification and secretin. (1971) (4)
Effect of duodenal fat on plasma levels of gastrin and secretin and on gastric acid responses to gastric and intestinal meals in dogs. (1978) (4)
Role of prostaglandins in alkaline secretion from the gastroduodenal mucosa exposed to acid and taurocholate. (1984) (4)
Aspirin-induced gastric ulcers in cats (1981) (4)
Results of long-term high frequency gastric electrical stimulation (GES) for treatment of gastroparesis refractory to standard medical therapy (2001) (4)
Gastrointestinal and liver physiology. Preface. (2008) (4)
Role of capsaicin-sensitive neurons in the control of intestinal blood flow and oxygen uptake. (1995) (4)
Feedback control of pancreatic secretion in rats. Role of gastric acid secretion. (1992) (4)
Effects of nocloprost on gastric functions in man. (1991) (4)
Comparison of prostaglandin I2 and E2 on gastric acid secretion and mucosal blood flow (1978) (3)
Efficacy of chronic gastric electrical stimulation in the treatment of symptomatic gastroparesis: results at 6 and 12 months from the WAVESS study (2000) (3)
Effects of growth hormone releasing factor on pancreatic secretion in vivo and in vitro (1989) (3)
Effects of human corticotropin releasing factor (CRF) on gastric and pancreatic secretion in vivo and in vitro (1987) (3)
Gastroprotection by Nonprostaglandin Substances (1989) (3)
Serum and saliva IgG and IgA antibody in Polish patients with Helicobacter pylori [Hp] infection in oral cavity and gastroduodenal disorders (1997) (3)
Effects of a novel H2-receptor antagonist containing piperidinomethyl group (IT-066) on gastric secretion in dogs and on acute gastric ulcers in rats (1992) (3)
Orexin-a Protects Gastric Mucosa Against Ethanol-Induced Injury: Role of Sensory Nerves and Heat Shock Proteins (2011) (3)
[Effect of met-enkephalin and morphine on the motor and myoelectric activity of the stomach]. (1979) (3)
Roleofmucosal prostaglandins andDNA synthesis ingastric cytoprotection byluminal epidermal growth factor (1981) (3)
Gastroprotection by antisecretory and non-antisecretory agents. (1986) (3)
Antagonism of histamine H2-receptors and gastric secretion. (1973) (3)
[Protective and therapeutic effect of leptin in acute pancreatitis evoked by ischemia/reperfusion]. (2003) (3)
Inhibition of the Renin-Angiotensin System protects gastric mucosa against ischemia/reperfusion injury (2001) (3)
Supralox: a novel aluminium containing antacid with gastroprotective and ulcer healing activity (1993) (3)
186 Beneficial Effects of Probiotic Saccharomyces boulardi and Rifaximine in Stress- and NSAID-Induced Exacerbation of Experimental Colitis (2012) (3)
Studies on the localization of secretin release from canine intestine. (1986) (3)
918 Involvement of Nitric Oxide and Prostaglandins in the Angiotensin 1-7 Induced Acceleration of the Healing of Experimental Gastric Ulcers (2010) (3)
The influence of gastrin analogues and 2-deoxy-d-glucose on bile secretion (1967) (3)
The Pilot Study of 3-Month Course of Melatonin Treatment in Patients With Nonalcoholic Steatohepatitis (2011) (3)
Obestatin Protects Gastric Mucosa Against Ethanol-Induced Injury (2011) (3)
Studies on the localization of secretin release from canine intestine. (1986) (3)
Gastroprotection by Nonprostaglandin Substances (1989) (3)
The prevalence of Helicobacter pylori (Hp) infection in long-term users of nonsteroidal antiinflammatory drugs (NSAIDS) (1998) (3)
Effect of N-alpha-methyl histamine on ulcer healing in rats (2004) (3)
Comparison of enterogastrone derived from various sections of the intestine. (1962) (3)
Nocloprost, a unique PGE2 analog, with local gastroprotective and ulcer healing activity. (1991) (3)
Nitric Oxide-Releasing Agents - A New Generation of Drugs for Gastrointestinal Diseases (2002) (3)
Role of cholecystokinin in postprandial and vagally stimulated duodenal and gallbladder motility in dogs. (1991) (3)
Effect of caerulein on histamine and pentagastrin-induced gastric secretion in man (1970) (3)
Vagal and hormonal influences on gastric secretion in duodenal ulcer disease (1976) (3)
The role of histamine receptors in the stimulation of gastric acid secretion (1974) (3)
Secretin, gastrin and pancreatic bicarbonate responses to meals varying in pH levels. (1978) (2)
Gastric Cytoprotection and Adaptation to Ethanol (2017) (2)
Alimentary tract andpancreas De-Nol stimulates gastric andduodenal alkaline secretion through prostaglandin dependent mechanism (1987) (2)
Pharmacology and clinical use of ranitidine. (1982) (2)
Comparison of biological activity and disappearance rates of synthetic big gastrin, little gastrin and minigastrin in the dog. (1980) (2)
Importance of nitric oxide (NO) and adenosine in the mechanism of gastric preconditioning induced by short ischemia. (2003) (2)
Epidermal growth factor (EGF) limits the pancreatic damage in ischemia/ireperfusion-induced pancreatitis (2000) (2)
Effects of secretin antibody on gastric acid inhibition and pancreatic bicarbonate stimulation by acidified liver extract meal in dogs. (1986) (2)
Abstracts of the sixth international conference on experimental ulcer (1988) (2)
Effects of peptide YY on pancreatic blood flow and oxygen consumption. (1992) (2)
Gastric protection by nocloprost against aspirin damage in humans. Possible role of epidermal growth factor. (1991) (2)
[Effect of caerulein on gastric secretion and peptic ulcer]. (1971) (2)
Adaptation of the pancreas to repeated caerulein administration in rats. A morphological and functional study. (1997) (2)
Gastric protection by nocloprost against aspirin damage in humans. Possible role of epidermal growth factor. (1991) (2)
[Clinical significance of gastrointestinal hormones]. (1972) (2)
Effect of caeruleins on histamine-induced gastric secretion and peptic ulcers in cats. (1972) (2)
Involvement of Renin-Angiotensin System and Vasoactive Angiotensin-(1–7) Metabolite of Angiotensin II in Gastric Mucosal Injury and Gastroprotection (2012) (2)
ROLE OF CCK IN THE CONTROL OF GASTRIC EMPTYING AND GASTRIC SECRETORY RESPONSE TO FATTY MEAL IN HUMANS (1994) (2)
Prostaglandins and gastrointestinal secretion and motility. (1978) (2)
Pharmacologic control of gastric acid secretion in peptic ulcer. (1983) (2)
Abstracts of the sixth international conference on experimental ulcer (1988) (2)
Mechanism of the inhibitory action of endogenous cholecystokinin and caerulein on pentagastrin--induced gastric secretion. (1972) (2)
Drug-induced inhibition of gastric secretion. (1976) (2)
Secretion of protein and epidermal growth factor (EGF) by transplanted human pancreas (1992) (2)
ROLE OF OPIATE PEPTIDES IN THE REGULATION OF GASTROINTESTINAL MOTILITY AND SECRETION (1981) (2)
Electrical activity of canine gallbladder. (1991) (2)
Clinical aspects of gastric protection (1984) (2)
Role of liver and intestines in the degradation of epidermal growth factor. (1990) (2)
Beneficial Effect of Exogenous and Endogenous Melatonin in the Experimental Model of Barrett's Esophagus in Rats (2011) (2)
Gastric acid inhibitory profile of ebrotidine, a novel H2-receptor antagonist in humans. (1992) (2)
Comparison of methionine-enkephalin and morphine in the stimulation of gastric secretion (1978) (2)
Distribution andrelease ofepidermal growth factor (1989) (2)
Mesenteric lymph node Tgammadelta cells induced by gastrectomy in mice suppress cell-mediated immune response in vitro via released TGF-beta. (2007) (2)
Protective effect of ghrelin in experimental acute pancreatitis (1999) (2)
Gastric Cytoprotection and Adaptation to Ethanol (2017) (2)
Ulcer healing in diabetic rats treated with aspirin, nitric oxide (NO)-derivative of aspirin and COX-2 inhibitor (2003) (2)
CCK receptors in release of pancreatic polypeptide (PP) in dogs (1989) (2)
Effect of dibutyryl cyclic AMP on gastric secretion and mucosal blood flow. (1980) (2)
Cyclic AMP and bicarbonate responses of the dog pancreas to vasoactive intestinal peptide (VIP) and secretion. (1976) (2)
[Physiology and pathophysiology of bile secretion]. (1980) (2)
The influence of gastrin analogues on gastric, pancreatic and bile secretion. (1967) (2)
Inhibition of stimulated exocrine pancreatic secretion by leptin (2000) (2)
W1717 Effect of Obestatin on Stress-Induced Gastric Lesions in Rat (2010) (2)
Intravenous amino acids and fat stimulated pancreatic secretion (1978) (2)
Distribution andrelease ofepidermal growth factor (1989) (2)
ROLE OF CCK IN THE CONTROL OF GASTRIC EMPTYING AND GASTRIC SECRETORY RESPONSE TO FATTY MEAL IN HUMANS (1994) (2)
Proceedings: Bicarbonate and cyclic AMP secretion in pure pancreatic juice: dose-response curves to synthetic secretin in man. (1975) (2)
Cholecystokinin exerts a tonic inhibitory influence on gastric acid secretion and gastrin release. (1992) (2)
Helicobacter pylori‐positive peptic ulcer patients do not adapt to aspirin (1998) (2)
Effect of urogastrone from adrenalectomized dogs on gastric secretion. (1963) (2)
Gastroprotection by antisecretory and non-antisecretory agents. (1986) (2)
Secretion of protein and epidermal growth factor (EGF) by transplanted human pancreas (1992) (2)
Heat shock protein 70 (HSP 70) in gastric mucosal damage and adaptation: Effects of Helicobacter pylori infection (1998) (2)
Action of prostacyclin (PGI2) and prostaglandin E2 (PGE2) on gastric secretion and mucosal blood flow in dogs. (1980) (2)
Intravenous amino acids and fat stimulated pancreatic secretion (1978) (2)
Effect of orally administered 15(R)-15-methyl prostaglandin E2 and/or an anticholinergic drug on meal-induced gastric acid secretion and serum gastrin level in man (1978) (2)
Capsulated mini-dose 13C-urea breath test for studies on the prevalence of H.pylori infection in children (1997) (2)
Editorial: Nicotine and gastro-intestinal secretions. (1972) (2)
Effect ofsecretin andjejunal acidification on gastric andpancreatic secretion inman (1970) (2)
Ranitidine effect on gastric mucosa damage in patients with rheumatoid diseases on long-term treatment with non-steroid anti-inflammatory drugs. (1986) (2)
Role of prostaglandins, sensory nerves, nitric oxide and growth factors in gastric adaptation to topical irritants (1993) (2)
Role of prostaglandins, sensory nerves, nitric oxide and growth factors in gastric adaptation to topical irritants (1993) (2)
Effects of secretin antibody on gastric acid inhibition and pancreatic bicarbonate stimulation by acidified liver extract meal in dogs. (1986) (2)
Role of gastric acid secretion in the formation of gastric lesions induced by ischemia-reperfusion (1998) (1)
Effects of eradication of Helicobacter pylori (Hp) on mucosal expression and intragastric release of proinflammatory cytokines in humans (1998) (1)
Effect of methylated prostaglandin E2 analogue on canine and human gastric mucosa barrier. (1978) (1)
Acknowledgment to Referees (1995) (1)
Evidence against increased risk of Helicobacter pylori infection in dentists (1997) (1)
Decreased mRNA expression of EGF receptor ligands in Helicobacter polyri infected gastric mucosa (1998) (1)
Gastrin and intestinal phase of gastric secretion. (1980) (1)
Acceleration of ulcer healing by cholecystokinin (CCK). Role of CCK receptors, sensory nerves and nitric oxide (NO) (1998) (1)
CagA+ Helicobacter pylori (HP) strain delays gastric ulcer healing in mouse through induction of apoptosis (1998) (1)
Su1734 Impact of Probiotic Strain E.coli Nissle (EcN) on Gastric Mucosal Protection (2012) (1)
Ethanol suppresses Helicobacter pylori (HP) urease activity as measured by 13C-urea breath test (UBT) (1998) (1)
Involvement of nitric oxide (NO) in the mechanism of gastric preconditioning induced by short ischemia (2002) (1)
Nicotine and peptic ulcer (1971) (1)
Mo1087 Esophagoprotective Activity of Angiotensin-(1-7) in Rat Model of Acute Reflux Esophagitis. Role of Sensory Neuropetides and Proinflammatory Cytokines (2012) (1)
Neurohormonal control of pancreatic secretion. (1974) (1)
Coexpression of cyclooxygenase-2 (COX-2), hepatocyte growth factor (HGF) and gastrin in gastric cancer before and after eradication of Helicobacter pylori (Hp) (2001) (1)
The effects of neuropeptides: substance P, somatostatin, neurotensin and enkephalins on the myoelectric activity of the small intestine. (1987) (1)
Experimental and clinical studies on the prevention of aspirin-induced gastric damage by “cytoprotective” drugs (1987) (1)
Absorption of amino acids from the small bowel and their activity in releasing of cholecystokinin. (1977) (1)
Effect of Ethanol on Gastric Mucosa Pretreated with Prostaglandin a (1984) (1)
Inhibition of Gastric Acid Secretion (2011) (1)
Role of beta-adrenoceptors in gastric mucosal integrity and gastroprotection induced by epidermal growth factor. (1997) (1)
Difference in the action of human pancreatic polypeptide (PP) and its C-terminal hexapeptide on pancreatic secretion in man and dog (1980) (1)
Increased gastroesophageal reflux in diabetes mellitus (1998) (1)
Electrolyte barrier and histologic pattern of the gastric mucosa in man. (1971) (1)
T1072 Influence of L-Tryptophan and Melatonin On Gastric Mucosal Damage Induced By Aspirin in Men (2008) (1)
Severe atrophic gastritis with extreme hypergastrinemia and gene expression of ornithine decarboxylase (ODC) and cyclo-oxygenase-2 (COX-2) expression: comparison with gastric cancer. (2004) (1)
Gastric acid response to topical or intravenous histamine and topical H2-receptor blockade in dogs (1981) (1)
New aspects of clinical pharmacology of antacids. (1993) (1)
Effects of substance P on intestinal circulation and oxygen consumption. (1987) (1)
[Comparative studies on male and female urogastrone in dogs]. (1960) (1)
Clinical uses of prostaglandins in peptic ulcer disease (1988) (1)
The effect of sham feeding on pancreatic secretion: preliminary observations. (1987) (1)
[Candidiasis in the experimental model of ulcerative colitis]. (2007) (1)
Expression and functional role of serine/threonine phosphatases in rat esophagus. (2004) (1)
Mouse model of gastric infection with cytotoxin‐expressing strain of Helicobacter pylori in studying of pathogenesis of chronic gastric ulcer (1998) (1)
[The role of cholecystokinin in the regulation of intestinal blood circulation and metabolism]. (1990) (1)
TREATED WITH NATIVE ASPIRIN, NITRIC OXIDE (NO)-DERIVATIVE (2004) (1)
The effects of neuropeptides: substance P, somatostatin, neurotensin and enkephalins on the myoelectric activity of the small intestine. (1987) (1)
[Gastrointestinal motility]. (1976) (1)
Augmentation of secretin-induced pancreatic secretion by caerulein (1972) (1)
Gastrin and cyclooxygenase-2 (COX-2) expression in Helicobacter pylori (Hp) infected gastric ulceration (2001) (1)
Role of cyclooxygenase (COX)-1 and COX-2 dereivatives in acceleration of the ulcer healing by growth factors (2000) (1)
Pancreatic dose response to synthetic secretin and intraduodenal acid in dogs (1970) (1)
Effect of 16, 16-dimethyl prostaglandin E2 methyl ester on gastric secretion induced by pentagastrin and pepton meal in man. (1976) (1)
Luminal somatostatin inhibits gastric and pancreatic secretion in response to endogenous and exogenous stimulants (1980) (1)
[Pharmacological inhibition of gastric secretion and treatment of peptic ulcer]. (1978) (1)
Effect of vagotomy and pyloroplasty on pancreatic dose-response curves to secretin in man (1971) (1)
W1725 Importance of Epi-Lipoxin A4 and Nitric Oxide (NO) in the Mechanism of Adaptation of Gastric Mucosa to Continuous Aspirin Administration (2008) (1)
Adaptation to alcohol is associated with overexpression of heat shock proteins (HSP) (1998) (1)
Central and peripheral gastroprotective and secretory activity of histamine and its N-alpha methyl analog (2001) (1)
Gastroprotective Activity of Grapefruit (Citrus paridisi) Seed Extract Against Acute Gastric Lesions (2011) (1)
Effects of eradication of Helicobacter pylori (Hp) on mucosal expression and intragastric release of proinflammatory cytokines in humans (1998) (1)
Severe atrophic gastritis with extreme hypergastrinemia and gene expression of ornithine decarboxylase-2 (Cox-2) expression: comparison with gastric cancer (2004) (1)
Effect of vasodilators on lipid peroxidation and antioxidative mechanisms in gastric mucosa (1999) (1)
[The role of the intestine in the regulation of gastric secretion]. (1969) (1)
995 Role of Nesfatin-1, the Novel Satiety Hormone, in the Mechanism of Gastric Mucosal Defense. Importance of Endogenous Prostaglandins and Sensory Afferent Nerves (2009) (1)
Isolation and characterization of the new biologically active peptide VQY from porcine gut (1985) (1)
Double-blind placebo-controlled study on the effect of sucralfate on gastric biosynthesis of prostaglandin in normal and aspirin-treated humans. (1987) (1)
Action of substance P (SP) and its C-terminal hexapeptide on gastrointestinal secretions and circulation (1980) (1)
Gastrointestinal secretory function during physical exercise. (1974) (1)
Cck antagonism by loxiglumide and potentiating interaction between secretin and cck on pancreatic secretion in humans (1989) (1)
Decreased mRNA expression of EGF receptor ligands in Helicobacter polyri infected gastric mucosa (1998) (1)
Eradication ofHelicobacter pyloriRestores the Inhibitory Effect of Cholecystokinin on Gastric Motility in Duodenal Ulcer Patients (2001) (1)
[Effect of nicotine on the development of peptic ulcer]. (1972) (1)
Effect of intestinal hormones on pentagastrin- and histamine-evoked gastric acid secretion and duodenal ulcerations in cats (1973) (1)
Second International Conference on Gastrointestinal Hormones (1979) (1)
S1639 Effect of Helicobacter pylori Infection on the Phenomenon of Gastric Mucosal Adaptation to Repetitive Aspirin Insult in Mongolian Gerbils. Role of Reactive Oxygen Metabolites and Proinflammatory Cytokines (2010) (1)
Mouse model of gastric infection with cytotoxin‐expressing strain of Helicobacter pylori in studying of pathogenesis of chronic gastric ulcer (1998) (1)
Antacids and mucosal protection : Antacids (1992) (1)
Contents Vol. 45, 1999 (1999) (0)
Evidence for impaired gastric acid secretion in H.pylori gastritis with antigastric autoantibodies (1997) (0)
Professor Jerzy Kaulbersz, pioneer of Polish gastroenterology. (2011) (0)
Effect of prostacyclin on pancreatic secretion in dogs. (1980) (0)
Detection of cytokine transcripts in rat gastric mucosa after exposure to stress using the reverse transcriptase polymerase chain reaction (1995) (0)
Influence of sensory nerves and CGRP on the course of experimental pancreatitis and pancreatic regeneration (2001) (0)
Mucosal expression and luminal release of transforming growth factor [TGFalpha] and epidermal growth factor [EGF] in duodenal ulcer [DU] before and after eradication of Helicobacter pylori [Hp] (1997) (0)
Nitric oxide (NO) in pancreatic response to intestinal and sensory neural stimulation (1998) (0)
Involvement of endogenous leptin in gastroprotection and adaptation of gastric mucosa to H. pylori-derived lipopolysaccharides (Hp-LPS) (2000) (0)
The role of oxygen-derived free radicals in acute pancreatitis (1998) (0)
Cholecystokinin (CCK) in fat- and acid-induced inhibiton of gastric secretion (1992) (0)
[Dose-response correlation for pancreatic secretion in dogs stimulated by exogenous and endogenous cholecystokinin]. (1972) (0)
[The use of pure natural secretin in the determination of maximum pancreatic secretion]. (1970) (0)
Gastrin-induced protection against ethanol damage involves an overexpression of histidine decarboxylase (HDC) and histamine release (2000) (0)
Role of polypeptide growth factors in gastric mucosa (1992) (0)
[DIET AND HYPERTENSION IN THE DEVELOPMENT OF ARTERIOSCLEROSIS]. (1964) (0)
[Role of antral gastrin in regulating gastric secretion and bile flow]. (1977) (0)
Effect of pyloric transection on gastric and pancreatic secretion. (1986) (0)
[A method of inducing peptic ulcer in cats by intravenous infusion of pentagastrin]. (1969) (0)
[Studies on the influence of fat, glucose, saline and peptone solution on gastric motility in rats]. (1970) (0)
Caerulein modulates the ghrelin system in the pancreatic acini (2012) (0)
The use of natural secretin in the determination of maximal pancreatic secretion in man. (1971) (0)
W1545 Importance of Naringin and Hesperidin in the Antisecretory, Gastroprotective and Ulcer Healing Actions of Grapefruit Seed Extract (2009) (0)
[Effect of hypophysectomy, ACTH and cortisone on experimental peptic ulcer produced by Shay's method]. (1959) (0)
Impaired gastric ulcer healing in diabetic rats: Role of angiogenesis, growth factors, heat shock protein and proinflammatory cytokines (2003) (0)
[Advances in gastrointestinal endocrinology]. (1972) (0)
[New methods of creating a chronic pancreatic fistula in cats]. (1970) (0)
100 Appetite Hormones Ghrelin, Orexin and Obestatin Are Involved in the Mechanism of Gastric Ulcer Healing (2008) (0)
The role of nitric oxide synthase inhibition in the platelet function (1994) (0)
Subject Index Vol. 57, 1996 (1996) (0)
Sa2024 Involvement of Gastric Secretion and Primary Capsaicin-Sensitive Afferent Nerves in the Gastroprotection Induced by Hydrogen Sulfide in Rat Stomach (2013) (0)
[Proceedings: Bicarbonates and cyclic AMP in pure human pancreatic juice: dosage-effect curve with synthetic secretin]. (1976) (0)
Su1810 Role of Carbon Monoxide (CO) Released From Corm-2, a Co Donor, in Gastric Protection Against Acute Mucosal Injury (2013) (0)
[Effect of hypobaric hypoxia on pancreatic secretion stimulated by food and by intraduodenal infusion of hydrochloric acid (author's transl)]. (1974) (0)
[Hormones of digestive tract]. (1969) (0)
[Exogenous and endogenous secretion and gastric secretion and development of experimental peptic ulcer induced with pentagastrin]. (1969) (0)
Studies on the effect of fat as well as of glucose, sodium chloride and peptone solutions on gastric motility in rats. (1970) (0)
Helicobacter pylori attenuates the delay in ulcer healing induced by aspirin and selective COX-2 inhibitor (2002) (0)
[Local circulatory effects of pentagastrin]. (1977) (0)
ECL cells involvement in the isoproterenol-induced gastroprotection. An ultrastructural study. (1998) (0)
[Mechanisms inhibiting gastric secretion]. (1967) (0)
[Absorption of amino acids from the digestive system following the administration of albumin labeled with I-131]. (1962) (0)
[Blood levels of histamine in different stages of hypertension]. (1959) (0)
Mo1251 Effect of Rifaximin Therapy on the Plasma Level of Asymmetric Dimethylarginine (ADMA) and Melatonin in Patients With Liver Cirrhosis (2015) (0)
Ulcer diseases ( including NSAIDs ) 10 . 01 Helicobacter pylori infection increases the risk of gastro-duodenal damage in elderly subjects taking low-dose aspirin (2002) (0)
Su1765 Diabetes Impairs the Acceleration of Healing of Preexisting Gastric Ulcers Induced by Food Intake Controlling Hormones Orexin-a and Nesfatin-1 (2012) (0)
Epidermal growth factor (EGF) and platelet function before and after exercise (1992) (0)
The effect of glucagon on pancreatic secretion and plasma secretin in dogs. Invited commentary. (1977) (0)
Contribution of prostanoids to gastric circulatory and metabolic actions of solcoseryl. (1990) (0)
Gastric secretory andplasma hormonal responsesto sham-feeding ofvaryingduration inpatients with duodenal ulcer (1981) (0)
[Intravenous infusion of ascitic fluid with control of the central venous pressure in treatment of hepatic cirrhosis]. (1968) (0)
[The effect of gastrin related peptides on HC1 secretion from the vagally innervated and denervated portions of the stomach]. (1968) (0)
Endogenous CCK in the Control of Gastric Secretory Response to Meal in Normal Subjects and Duodenal Ulcer Patients (1994) (0)
T1966 Effect of Non-Selective and Selective Cyclooxygenase (COX)-2 Inhibitors and Nitric Oxide (NO)-Releasing Aspirin On Esophageal Damage in the Rat Model of Reflux Esophagitis (2008) (0)
Comparison of gastric mucosal damage and prostaglandin formation in arthritis patients treated with carprofen and ibuprofen (1987) (0)
Gastric cytoprotection. (1982) (0)
M1735 Impact of Obstructive Sleep Apnea on Circadian Variations of Plasma Melatonin and Feed Regulating Peptides (2010) (0)
Management of Helicobacter pylori-related disorders. Discussion (1997) (0)
[THE EFFECT OF ADRENALS ON THE ABSORPTION AND DISTRIBUTION OF FATE IN TISSUES]. (1965) (0)
[Effect of Atromid S on lipid metabolism in coronary insufficiency]. (1968) (0)
Leptin accelerates ulcer healing due to overexpression of growth factors and nitric oxide synthase (2000) (0)
CHEMICALLY AND g-RADIATION INDUCED APOPTOSIS (2008) (0)
[EFFECT OF THYROIDECTOMY, ADRENALECTOMY AND CASTRATION ON THE APPEARANCE OF GASTRIC ULCER AND ON GASTRIC SECRETION IN THE RAT]. (1963) (0)
[Effect of urogastrone on gastric secretion in adrenalectomized dogs]. (1960) (0)
S1749 Treatment With Ampicillin Reverses the Impairment in Healing of Ulcerative Colitis Induced by Conventional NSAIDs and Selective COX-2 Inhibitors (2010) (0)
Invited commentary (2005) (0)
Release of secretin and cholecystokinin in the duodenum and small intestine. (1972) (0)
Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression and functional impairment in Helicobacter pylori (Hp)-Infected mongolian gerbis (2003) (0)
[The inhibitory effect of secretin on gastric acid secretion]. (1970) (0)
[TETRACYCLINE TEST IN GASTRIC CARCINOMA]. (1965) (0)
Contents Vol. 68, 2003 (2004) (0)
[Comparison of the maximum histamine test with gastrin evoked gastric secretion in man]. (1966) (0)
[The role of cholecystokinin receptors in the regulation of the circulation and oxygen consumption in the pancreas]. (1990) (0)
Effect of treatment with specific COX-2 inhibitor(rofecoxib) on the expression of apoptosis-related proteins, progastrin, gastrin, COX-2 and Pparγ in gastric cancer patients (2003) (0)
[Comparative studies on enterogastrone originating in various segments of the intestine in dogs]. (1960) (0)
Role of pancreatic secretory trypsin inhibitor (PSTI) in healing of chronic gastric ulcers in rats (1998) (0)
Gastrointestinal effects of somatostatin - physiology and clinical application. (1980) (0)
[Tests of gastric secretion]. (1969) (0)
[Electrolyte barrier in gastric mucosa]. (1972) (0)
[Peptic ulcer and gastrointestinal hormones]. (1971) (0)
[Effect of reserpine on gastric function]. (1961) (0)
Gastric acid andpancreatic polypeptide responses to modified shamfeeding. Effects oftruncal andparietal cell vagotomy (1987) (0)
642 Interaction of Epidermal Growth Factor (EGF) With Cyclooxygenase-2 Products and Peroxisome Proliferator-Activated Receptor Gamma (PPARy) System in the Pathogenesis of Esophageal Damage in Rat Model of Barrett's Esophagus (2012) (0)
Plasma level and pancreatic gene expression of leptin in acute pancreatitis in rats and in acute and chronic pancreatitis in humans (2001) (0)
The role of the intestine in the regulation of gastric secretion. (1970) (0)
M1721 Involvement of Food Intake Controlling Hormones Obestatin, Ghrelin and Orexin in the Mechanism of the Healing of Preexisting Gastric Ulcers (2010) (0)
Subject Index Vol. 68, 2003 (2004) (0)
[Studies on the potentiating effect of pentagastrin and histamine on the gastric secretion in man]. (1970) (0)
[Application of the quantitative radiocardiography in hemodynamic studies]. (1965) (0)
632 Involvement of Cannabinoid CB1 Receptors and Calcitonin Gene Related Peptide (CGRP) in the Gastroprotective Action of Endocannabinoids Against Acute Gastric Lesions (2008) (0)
[KINETICS OF LYMPH LIPOPROTEINS LABELED WITH I-131 FROM THE BLOOD IN DOGS]. (1964) (0)
[Secretin and calcium tests in patients with peptic duodenal ulcer and hyperchlorhydria (author's transl)]. (1975) (0)
Professor Jerzy Kaulbersz, pioneer of Polish gastroenterology. (2011) (0)
[Determination of proteolytic activity of gastric juice by means of 131-I-albumin]. (1969) (0)
Gastric adaptation to aspirin (ASA) is associated with increased expression of heat shock protein (HSP 70) and decreased apoptosis due to downregulation of bax (2000) (0)
Reply—Helicobacter pylori‐gastrin link in malt‐lymphoma (2001) (0)
Ebrotidine vs ranitidine in quality healing of duodenal ulcer (1995) (0)
Letters to the editor (1990) (0)
Clinical aspects of gastric cytoprotection. (1985) (0)
Circulatory and metabolic effects of neuropeptides in stomach and intestine. (1987) (0)
[Effect of metiamide, an antagonist of histamine H2-receptors, on gastric secretion (author's transl)]. (1974) (0)
Subject Index, Vol. 34, 1986 (1986) (0)
Affinity of some fluorescent substances for neoplastic tissues and its diagnostic significance. (1963) (0)
Leptin protects the pancreas against its damage by overstmulation with caerulein. Role of TNFA and IL-4 (2000) (0)
Tu1665 Role of Ghrelin and Melatonin in Pathogenesis of Clinical and Experimental Inflammatory Bowel Disease (2013) (0)
Letters to the editor. (1990) (0)
[Effect of caerulein on basal and histamine-induced gastric secretion in man]. (1972) (0)
Pioglitazone, a specific PPAR-γ ligand, accelerates ulcer healing. Importance of proinflammatory cytokines, cyclooxygenase-2, inducible NO-synthase and heat shock protein 70 expression (2003) (0)
Pancreatic gene expression for cytokines, nitric oxide synthase and for tryptophan hydroxylase in human pancreatitis (AP) (2003) (0)
[Secretion of the gastric mucosa and its morphology]. (1969) (0)
Interaction of Helicobacter pylori (Hp) with NSAID and coxibs on healing of preexisting gastric ulcerations in rats (2003) (0)
[Blockade of histamine receptors H-2 and gastric secretion]. (1974) (0)
Sections Vol. 68, 2003 (2004) (0)
Tu1852 Esophagoprotection Mediated by Exogenous and Endogenous Melatonin in an Experimental Model of Reflux Esophagitis (2013) (0)
[Neurohormonal regulation of the secretion of digestive glands]. (1970) (0)
Effects of prosomatostatin (S-28) and somatostatin (S-14) on exocrine and hormonal pancreatic responses to sham-feeding in dogs (1982) (0)
T1754 Acceleration of the Healing of Preexisting Gastric Ulcers by Nesfatin-1, the Novel Satiety Hormone. Role of PG/COX-2 System and Sensory Nerves (2010) (0)
Effect of exclusion, acidification, and excision of the duodenum on gastric acid secretion and the production of pentagastrin-induced peptic ulcer in cats. (1969) (0)
[Current principles of selection of the appropriate operation in cases of duodenal ulcer]. (1967) (0)
Helicobacter pylori promotes apoptosis, activates cyclooxygenase (COX)-2 and inhibits heat shock protein HSP70 in gastric cancer epithelial cells (2012) (0)
[Uptake and distribution of epidermal growth factor in certain organs of the dog]. (1991) (0)
Serological differentiation of Helicobacter pylori CagA[plus] and CagA[minus] infections (2003) (0)
Intracerebroventricular application of leptin protects gastric mucosa via enhancement of nitric oxide (NO) and sensory afferents (2000) (0)
T1288 Aspirin (ASA) and Its Nitric Oxide (NO) Derivative in the Healing of Colonic Damage in Experimental Model of Ulcerative Colitis (2008) (0)
EFFECT OF GASTRIC MUCOSAL BARRIER BREAKERS ON CANINE ALKALINE SECRETION AND TRANSMUCOSAL POTENTIAL DIFFERENCE (1981) (0)
[A NEW EXPERIMENTAL METHOD FOR THE PRODUCTION OF MYOCARDIAL INFARCT]. (1964) (0)
[Effect of hypophysectomy and ACTH administration on the development of experimental arteriosclerosis in rats]. (1968) (0)
Influence of Pancreatic Juice and Bile on the Motility of Stomach after Intra-intestinal Administration of Fat (1963) (0)
Contents Vol. 67, 2003 (2003) (0)
Comparison of central administration of melatonin precursor L-tryptophan on caerulein-induced pancreatitis (CIP) in rats (2003) (0)
Prevention of acute gastric mucosal lesions by Solcoseryl. (1987) (0)
Editorial: Nicotine and gastro-intestinal secretions. (1972) (0)
[Effect of hydrocortisone on gastric secretion and histology in Addison's disease]. (1972) (0)
Neuro-Hormonal Control of Gastric Acid Secretion: The Role of Histamine (1984) (0)
Functional aspects of gastric infection with Helicobacter pylori in Mongolian gerbils at early stage of adenocarcinoma formation (2001) (0)
Central and peripheral gastroprotective action of melatonin and its precursor, L-tryptophan, against stress-induced gastric lesions (2003) (0)
Ghrelin-induced molecular system in the pancreatic protection (2015) (0)
[Advances in physiopathology of the stomach]. (1966) (0)
[Tetracycline fluorescence in the diagnosis of malignant neoplasms]. (1962) (0)
[Nicotine and peptic ulcer]. (1971) (0)
Melatonin or L-Tryptophan Accelerates Healing of Gastroduodenal Ulcers in Men Treated With Omeprazole (2011) (0)
Acceleration of ulcer healing by N-alpha methythistamine (NαMH) in rats. Role of gastrin, DNA synthesis and CCKB/gastrin receptors (2001) (0)
Role of epidermal growth factor (EGF) and egf receptor in healing of stress lesions induced by leptin and cholecystokinin (CCK) (2000) (0)
[Pentagastrin in gastric secretory tests]. (1968) (0)
Remarks on 2$^{nd}$ polish conference of young physiologists entitled "Gastrointestinal functions in health and diseases" (2004) (0)
[The effect of the adrenal glands on the development of experimental atherosclerosis]. (1966) (0)
Abstracts of the Hans Selye Symposium on Neuroendocrinology and Stress (1989) (0)
Implication of reactive oxygen species (ROS) in gastroprotection and ulcer healing by nitric oxide (NO)-releasing aspirin (2000) (0)
W1123 Melatonin and Its Precursor, L-Tryptophan Exert Beneficial Effect Against Reflux Esophagitis via Activation of Melatonin Mel2 Receptors, NO/NOS System and Sensory Nerves (2010) (0)
Intracerebroventricular histamine and its N-alpha methyl analog protect the gastric mucosa via activation of vagal and adrenergic pathways and nitric oxide (NO) system (2003) (0)
Effects of CGRP and leptin on gene expression for TNF a and Ob receptor in AR42J cells subjected to caerulein overstimulation (2003) (0)
Role of Angiotensin 1-7 in Gastroprotection Against Stress-Induced Ulcerogenesis. Evidence for the Involvement of Mas Receptor, Prostanoids and Capsaicin-Sensitive Nerves (2011) (0)
Effect of locally applied growth factors and their antibodies on ulcer healing and mucosal expression of cyclooxygenase (COX)-1 and COX-2 (2000) (0)
1062 Ghrelin and Leptin Ameliorate the Experimental Esophagitis in Rats (2010) (0)
9 – Biological Activity of Motilin in Gastric, Pancreatic, and Duodenal Secretions (1990) (0)
Importance of reactive oxygen metabolites in Nitric Oxide (NO)-releasing (NSAID)-induced gastroprotection and mucosal recovery from stress injury (2001) (0)
[Effect of insulin and 2-desoxy-D-glucose on secretion of the normal and vagotomized stomach]. (1967) (0)
[Neurohormonal regulation of gastric secretion]. (1969) (0)
Colorectal cancer: trophic factors, COX-2 and apoptotic proteins status in patients before and after radiotherapy (2003) (0)
Tumor necrosis factor alpha (TNFα) plays a critical role in the pathogenesis of ischemia-reperfusion-induced gastric injury (2001) (0)
Progress in H.pylori related basic and clinical research in Poland (1997) (0)
[Experimental peptic ulcer in hypophysectomized rats]. (1957) (0)
[EFFECT OF THE PULMONARY CIRCULATION ON THE FAT CONTENT OF THE BLOOD]. (1963) (0)
Comparison of somatostatin (SS) and prosomatostatin (Pro-SS) on gastric and pancreatic secretions and plasma hormonal responses to cephalic stimulation (1983) (0)
[Influence of pregnancy on the healing of chronic gastric and duodenal ulcers. Role of endogenous epidermal growth factor]. (1989) (0)
The influence of caerulein analogues on gastric acid secretion and peptic ulcer production in cat. (1971) (0)
[Effect of surgical vagotomy on gastric secretion induced by pentagastrine and histamine]. (1968) (0)
The clinical value of the maximal histamine test. (1967) (0)
Pathologic basis of gastric mucosal adaptation to topical injury (1995) (0)
Pancreatic secretion and cyclic AMP in pancreatic tissue after intravenous infusion of secretin and vasoactive intestinal peptide in cats. (1980) (0)
Hepatocyte growth factor (HGF) and proinflammatory cytokines induce gastrin in hepatic cells: An important link in the development of hepatocellular carcinoma (HCC)? (2003) (0)
[Achievements in the field of gastroenterology during the last 30 years]. (1974) (0)
Effect of cerulein peptides on post-histamine gastric secretion and gastric ulcers in cats. (1973) (0)
[Absorption of olive oil labeled with I-131 from the digestive system]. (1962) (0)
[GASTRIC FUNCTION DISORDERS IN SHEEHAN'S SYNDROME PATIENTS AND IN HYPOPHYSECTOMIZED RATS]. (1964) (0)
[Neurohormonal cooperation in the secretory activity of the stomach and pancreas]. (1980) (0)
Curcumin Affords Gastroprotection Against Acute Gastric Lesions Induced by Acid-Independent and Acid-Dependent Ulcerogens. Involvement of Prostaglandins, Sensory Neuropeptides and Vanilloid TRPV-1 Receptors (2011) (0)
Involvement of prostaglandins (PG), nitric oxide (NO) and adenosine (ADE) in the mechanism of gastric preconditioning induced by short ischaemia (2000) (0)
Nα-methyl histamine inhibits pancreatic secretion and caerulein-induced pancreatitis in rats (2001) (0)
[Comparative studies on enterogastrone originating from various segments of the intestine]. (1962) (0)
[Current methods in the diagnosis of gastritis]. (1969) (0)
Invited commentary (2005) (0)
Gastrin, gastrin receptors (CCK4-R) and nitric oxide (NO) are involved in the enhanced ulcer healing induced by leptin (2001) (0)
Gastric adaptation to aspirin and Helicobacter pylori infection in man (1998) (0)
[Comparative studies on enterogastrone from various segments of the intestines]. (1957) (0)
Comparison of neurotensin and oleate on exocrine and endocrine pancreatic secretion (1982) (0)
[EFFECT OF LARGACTIL AND PHENERGAN ON GASTRIC SECRETION AND DEVELOPMENT OF EXPERIMENTAL PEPTIC ULCER]. (1964) (0)
[Microcirculatory effects of prostacyclin on blood circulation in the mesentery and limbs]. (1982) (0)
Overexpression of epidermal growth factor receptor in gastroduodenal mucosa during pregnancy accelerates healing of chronic ulcers (2000) (0)
Prostaglandins in the mediation of secretin-induced inhibition of gastric secretion and stimulation of pancreatic secretion. (1989) (0)
Inhibition of apoptosis by growth factors and prostaglandin — A key event in healing of stress damage? (2000) (0)
T1902 Effect of Selective and Non-Selective Cyclooxygenase (COX)-1 and COX-2 Inhibitors and Nitric Oxide Releasing Aspirin (No-ASA) On the Chronic Esophagitis in the Rat Model of Barrett's Esophagus (2009) (0)
[Effect of atropine on post-histamine and post-gastrin gastric secretion in duodenal ulcer before vagotomy with pyloroplasty and following surgery]. (1969) (0)
Su1755 Hydrogen Sulfide Exhibits a Potent Gastroprotective Action Against Stress-Induced Gastric Lesions. Involvement of Prostaglandins and Sensory Afferents (2012) (0)
Role of Endogenous Melatonin in Amelioration of Nonalcoholic Fatty Liver Disease (NAFLD) in Rats (2011) (0)
[Clinical value of the maximal histamine test in association with conservative vagotomy]. (1967) (0)
Involvement of reactive oxygen metabolites in gastroprotection induced by ischemic preconditioning of the stomach and remote organs (2003) (0)
Healing Effect of Ghrelin is Attenuated in Diabetic Rats (2011) (0)
[Clinical aspects of intestino-hepatic circulation of bile acids]. (1971) (0)
Neurohormonal interactions in the stomach and pancreas (1979) (0)
[Laboratory diagnosis of kidney diseases. 3. Function of the kidneys]. (1974) (0)
[Electrolyte barrier and histological appearance of gastric mucosa in man]. (1971) (0)
W1694 Role of Asymmetric Dimetylarginine (ADMA), an Endogenous Inhibitor of Nitric Oxide (NO) Synthase in the Pathogenesis of Ischemia-Reperfusion Injury and Healing of Preexisting Gastric Ulcers (2010) (0)
Comparison of systemic and local application of growth factors on gastric secretion and ulcer healing (2001) (0)
T1835 1-Methylnicotinamide Accelerates Gastric Ulcer Healing Via An Activation of Cyclooxygenase (COX)-2/Prostacyclin System and Sensory Nerves (2008) (0)
Induction of apoptosis in gastric mucosa by acute stress injury (1998) (0)
[TRANSPORT OF FATS THROUGH THE THORACIC DUCT]. (1963) (0)
Peptic ulceration in dyspeptic population as a result of H. pylori infection, non-sterroidal anti-inflammatory drugs (NSAID), age and smoking (2003) (0)
Seminars on Ulcer Healing (1993) (0)
Brain–Gut Axis and Neural Control (2014) (0)
[The role of gastrins in physiopathology of the stomach in view of immunochemical studies (author's transl)]. (1974) (0)
[Electrolyte gastric mucosa barrier and hydrochloric acid secretion in man]. (1971) (0)
[Action of vasodilator agents in experimental mesenteric circulatory failure]. (1981) (0)
Alive H. pylori but not the product of caga gene triggers proapoptotic changes in bax and BCL-2 status and in heat shock proteins (HSP) system in cultured KATO III cells (2000) (0)
P037 Role of ghrelin and melatonin in pathogenesis of clinical and experimental inflammatory bowel disease (2013) (0)
Inhibition of cyclooxygenase-2 reduces the protective effect of hepatocyte growth factor administration in experimental pancreatitis (2003) (0)
Significance of neuropeptides released from afferent sensory nerves and cyclooxygenase (COX)-derived prostaglandins in adaptive cytoprotection induced by mild irritants (2000) (0)
Contents Vol. 57, 1999 (1999) (0)
W1783 Effect of Combined Antifungeal and Probiotic Therapy On Candida Colonization of Human Ulcerative Colitis and the Healing of Colonic Injury in Experimental Animal Model of Colitis Ulcerosa (2008) (0)
[New methods of studying pancreatic secretion]. (1970) (0)
S1623 Dynamic Physiological and Molecular Changes in Gastric Ulcer Healing By Melatonin and Its Precursor, L-Tryprophan, in Rats (2008) (0)
1012 Gastroprotective Activity of Probiotic Bacteria Lactobacillus and Escherichia coli Nissle 1917 Against Acute Gastric Mucosal Injury in the Rat Stomach Is Mediated By Endogenous Prostaglandins and Nitric Oxide (NO) (2008) (0)
[Effect of preventive vagotomy on the gastric acid secretion in duodenal ulcer after pentagastrin and histamine]. (1968) (0)
[Study of the acidity of gastric contents determined by pH-metry after fractional administration Of Krynica mineral water Zuber III]. (1988) (0)
Ebrotidine: A Viewpoint (1996) (0)
Contents Vol. 66, 2002 (2002) (0)
Sections Vol. 66, 2002 (2003) (0)
Expression of Helicobacter pylori (Hp) and chlamydia pneumoniae (Cp) dna in coronary vessels of patients with coronary heart disease (CHD) (2000) (0)
Mucosal adaptation toaspirin induced gastric damageinhumans. Studies on bloodflow, gastric mucosal growth, andneutrophil activation (1994) (0)
Ebrotidine, a unique H-2-receptor antagonist, with gastroprotective activity against acid-dependent and acid-independent ulcerogens (1997) (0)
Reply (1987) (0)
Melatonin in Control of Gastric Secretion and Prevention of Gastric Mucosal Lesions (2011) (0)
Serum gastrin andgastric acid responses tomeals at variouspHlevels inman (1974) (0)
W1854 Treatment with Appetite Hormones Ghrelin and Leptin Exerts Beneficial Effect On Esophageal Mucosa in Rat Model of Reflux Esophagitis (2009) (0)
Sections Vol. 67, 2003 (2003) (0)
[Peptic ulcer and chronic cor pulmonale syndrome]. (1969) (0)
Gastric adaptation to aspirin and Helicobacter pylori infection in man (1998) (0)
Contents, Vol. 34, 1986 (1986) (0)
[PROGRESS IN THE TREATMENT OF PEPTIC ULCER]. (1964) (0)
9 – Biological Activity of Motilin in Gastric, Pancreatic, and Duodenal Secretions (1990) (0)
Subject Index, Vol. 34, 1986 (1986) (0)
Virulence factors ( Cag PAI , Vac A , iceA , babA ) 3 . 01 * The detection of tyrosine-phosphorylated CagA and SHP-2 tyrosine phosphatase in the biopsy of Helicobacter pylori positive patients (2002) (0)
Effect of synthetic 15-methyl analog of PGE2 on gastric acid and serum gastrin response to peptone meal, pentagastrin, and histamine in duodenal ulcer patients (1976) (0)
[Advances in the diagnosis and treatment of the secondary syndromes of intestinal malabsorption]. (1966) (0)
[Endocrine and exocrine gastric mucosal secretion in the course of H. pylori eradication in patients with non-ulcer dyspepsia]. (1997) (0)
[Studies on the effect of Krynica mineral water from the "Zuber" spring on alcohol-damaged gastric mucosa in rats]. (1989) (0)
Intraductal ultrasound (IDUS) in preoperative staging of tumors of the papilla of Vater (1997) (0)
Peptic Ulcer Disease (2014) (0)
Expression of TGF-B− and its receptor-mrnas in early gastric ulcer healing and atrophic gastritis (2000) (0)
180 Involvement of Asymmetric Dimetylarginine (ADMA), An Endogenous Inhibitor of Nitric Oxide (NO) Synthase, in the Pathogenesis of Acute Gastric Lesions (2009) (0)
Enhanced expression of leptin gene in acute gastric mucosal injury (2000) (0)
[Effect of tobacco smoking on gastric and pancreatic secretory activity in man]. (1972) (0)
182 L-Tryptophan Rich Diet Accelerates Gastric Ulcer Healing via Increase in Endogenous Melatonin, Prostaglandin Generation and Downregulation of Hypoxia Inducible Factor-1alpha (2009) (0)
Gastric adaptation to aspirin and Helicobacter pylori infection in man (1998) (0)
W1736 Gastroprotective Effect of E. Coli Nissle (Mutaflor): Evidence from In Vivo and In Vitro Studies (2008) (0)
883 Helicobacter pylori-Derived HP (2-20) Stimulates Gastric Mucosal Recovery From Stress-Induced Gastric Lesions and Accelerates the Healing of Chronic Gastric Ulcers (2010) (0)
Advances in the pathophysiology of the stomach. (1966) (0)
Acknowledgement to Referees (2009) (0)
M1640 Helicobacter pylori Infection and Plasma Ghrelin and Gastrin Levels in Gastric Cancer Patients Before and After Gastrectomy (2009) (0)
Expression of apoptosis related proteins bax and bcl-2 and growth factors in human gastric adenocarcinoma (2000) (0)
Hepatocyte growth factor (HGF) and proinflammatory cytokines induce gastrin in hepatic cells: an important link in the development of hepatocellular carcinoma (HCC)?? (2003) (0)
[Role of the cholinergic system in the control of pancreatic secretion]. (1972) (0)
Role of prostaglandins, nitric oxide (NO) and cytokines in gastroprotection by PPARgamma agonist against ethanol and stress-induced gastric lesions (2003) (0)
Gastric adaptation to aspirin and Helicobacter pylori infection in man (1998) (0)
Letter: Metiamide and aminopyrine clearance. (1975) (0)
The intrafamilial status of H. pylori (HP) infection in HP positive pediatric patients (2003) (0)
[EFFECT OF GASTRIC COOLING ON THE COURSE OF ULCEROUS DISEASE IN HUMANS AND ON THE DEVELOPMENT OF PEPTIC ULCER IN ANIMALS]. (1964) (0)
Differential expression of c-jun and c-myc protooncogenes during gastric ulcer development (1998) (0)
Epidermal growth factor (EGF) accelerates mucosal recovery from stress induced gastric lesions via inhibition of apoptosis and upregulation of Bcl-2 (2001) (0)
Subject Index Vol. 66, 2002 (2003) (0)
antibody to transforming growth factor beta 1 . ulcers by local injection of neutralising Acceleration of wound healing in gastric (2006) (0)
BRIEF COMMUNICATION NITRIC OXIDE SYNTHASE INHIBITION AND PLATELET FUNCTION (1994) (0)
treated man . microbleeding in normal and aspirin prostaglandin formation and effect of sucralfate on gastric Double blind controlled study on the (0)
Opie’s Common Channel Hypothesis (2004) (0)
Pathologic basis of gastric mucosal adaptation to topical injury (1995) (0)
[Hormones of the digestive tract]. (1969) (0)
Vagotomy prevents from the development of acute pancreatitis (AP) (2003) (0)
[Effect of secretine and atropine on alimentary gastric secretion (author's transl)]. (1975) (0)
Gastrin, cyclooxygenases in gastric MALT-lymphoma before and after eradication of Helicobacter pylori (HP) (2001) (0)
DAMAGE: ROLE OF INDUCIBLE NITRIC OXIDE SYNTHASE (2006) (0)
eradication of Helicobacter pylori . patients with duodenal ulcer before and after inepidermal and transforming growth factors Mucosal expression and luminal release of and (0)
[Hormonal changes and secretion and stomach mucosal microstructure in the course of H. pylori in patients with duodenal ulcer]. (1997) (0)
Expression of PDGF, bFGF, EGF and TGFα and their receptors during healing of chronic gastric ulcerations in rats (1995) (0)
Serum and gastric juice CagA antibody in H.pylori [Hp] infected patients (1997) (0)
Helicobacter pylori (HP) infection delays healing of ischemia-reperfusion (I/R)-induced gastric ulcerations: A new model for studying pathogenesis of HP-infection in the rat stomach (1998) (0)
Ghrelin and Stress Protection (2007) (0)
[Clinical aspects of gastric secretion]. (1971) (0)
Calcitonin gene-related peptide (CGRP) can prevent or augment pancreatic damage in caerulein-induced pancreatitis (1998) (0)
Epidermal growth factor (EGF) limits pancreatic damage and accelerates pancreatic recovery after caerulein-induced pancreatitis (1998) (0)
Leptin is involved in the protective effect of lipopolysaccharide [LPS] in the caerulein-induced pancreatitis (2001) (0)
Gastric acid secretion has protective influence on gastric mucosa against ammonia-induced damage in rats (1998) (0)
Gastric mucosa repeatedly exposed to Helicobacter pylori (HP) lipopolysaccharide (LPS) shows increased tolerance to injury via ions, COX-2 and HSP 70 mechanisms (1998) (0)
9th Meeting of the European Association for the Study of the Liver (Part 2 of 4) (1974) (0)
Effects of ammonia and alkalization on secretory activity of isolated rat pancreatic acini (1997) (0)
Protective effect of gastric acid secretion in ammonia induced gastric lesions (1997) (0)
Contents, Vol. 34, 1986 (1986) (0)
9th Meeting of the European Association for the Study of the Liver (Part 1 of 4) (1974) (0)
Role of nitric oxide in the pancreatic vascular and metabolic responses associated with activation of capsaicin-sensitive neurons. (1996) (0)
Gastric ulcer healing in mouse model of infection with cytotoxin expressing strain of Helicobacter pylori (1997) (0)
Melatonin and its substrate L-tryptophan (TRP) accelerate the healing of chronic gastric ulcers. Role of prostaglandins (PG), nitric oxide (NO) and gastrin (1998) (0)
Melatonin and its role in oxidative stress diseases of oral cavity (2007) (0)
Clopidogrel Exacerbates Aspirin (ASA) Damage and Counteracts the Gastric Adaptation to Repetitive ASA Insult. Role of Hypoxia-Inducible Factor-1alpha, Heme Oxygenase-1 (HO-1) and Proinflammatory Cytokines (2011) (0)
Subject Index Vol. 67, 2003 (2003) (0)
Activation of genes for rat spasmolytic peptide (rSP) and transforming growth factor alpha (TGFα) during adaptation to aspirin injury (1998) (0)
Stimulation of sensory nerves and CGRP administration attenuates development pancreatitis evoked by ischemia-reperfusion (2001) (0)
9th Meeting of the European Association for the Study of the Liver (Part 4 of 4) (1974) (0)
Gastroprotective and antisecretory activity of duodenal oleate. Implication of cholecystokinin (CCK), CCK-A receptors and somatostatin (SOM) (1998) (0)
Influence of ammonia (NH4OH) and H. Pylori lipopolysaccharide (HP-LPS) on gastric secretion in conscious dogs and rats (1998) (0)
Detection of cytokine transcripts in chronic gastric ulcers using the reverse transcriptase polymerase chain reaction. (1995) (0)
Pancreatic secretory trypsin inhibitor (PSTI) in healing of strees-induced gastric lesions in rats (1998) (0)
Acceleration of healing of gastric ulcers by local injection of neutralizing antibody (NA) to transforming growth factor B1 (1995) (0)
[DIAGNOSTIC DIFFICULTIES IN HYPERTHYROIDISM ASSOCIATED WITH ADRENAL INSUFFICIENCY]. (1963) (0)
AGAINST MUCOSAL INJURY INDUCED BY NOXIOUS AGENTS (2006) (0)
Protection of the acinar cells by lipopolisaccharide (LPS) in acute caerulein-induced pancreatitis. Role of endogenous nitric oxide (NO) and prostaglandin (PG) (1998) (0)
Subject Index Vol. 56, 1995 (1995) (0)
Prevalence of Helicobacter pylori infection in adult population of urban South-Poland Region related to gastric symptomatology (1997) (0)
Expression of TGFα and EGF in gastric mucosa after exposure to stress in rats (1995) (0)
THE SECRETORY AND CIRCULATORY EFFECTS OF PACAP ON THE RAT PANCREAS (1994) (0)
Brain-gut axis; historical background and present development (2001) (0)
Brain-gut axis in ischemic preconditioning of gastro-duodeno-pancreatic cluster (2001) (0)
Helicobacter pylori causes the exacerbation of healed acetic acid induced chronic ulceration in rats (1998) (0)
Influence of methionine-enkephalin and morphine on the myoelectrical activity of the small bowel (1978) (0)
Role of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) derived prostaglandins (PG) in adaptive cytoprotection induced by mild stress (1998) (0)
Contents, Vol. 56, 1995 (1995) (0)
The effect of glucagon on pancreatic secretion and plasma secretin in dogs. Invited commentary. (1977) (0)
The role of apoptosis and cytokines in gastric preconditioning (2001) (0)
Enzyme secretion and generation of nitric oxide (NO) in the pancreas exposed to bacterial lipopolysaccharide (LPS) (1998) (0)
Pharmacological inhibition of gastric secretion and treatment of peptic ulcer (1978) (0)
Subject Index, Vol. 45, 1990 (1990) (0)
Brain-gut axis in gastroprotection by leptin and cholecystokinin [CCK] (2001) (0)
Effect of H.pylori eradication on gastric and gallbladder emptying in non ulcer dyspepsia [NUD] patients (1997) (0)
The reinfection of H.pylori two years after quadruple therapy for duodenal ulcer (1997) (0)
Nitric oxide (NO)-releasing aspirin (ASA) and naproxen (NAP) induce gastric adaptation but fail to strengthen mucosa defense against damage induced by strong irritants (1998) (0)
Effect of central administration of L-tryptophan [melatonin precursor] and luzindole [melatonin MT2 receptor antagonist] on the course of caerulein induced acute pancreatitis in the rat (2001) (0)

This paper list is powered by the following services:

Other Resources About Stanisław Konturek

en.wikipedia.org

What Schools Are Affiliated With Stanisław Konturek?

Stanisław Konturek is affiliated with the following schools:

Stanisław Konturek's Academic­Influence.com Rankings